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Rubella virus is a leading cause of birth defects due to infectious agents. When contracted 
during pregnancy, rubella infection leads to severe damage in fetuses. Despite its medical 
importance, very little is known about the structure of the pleomorphic rubella virus as 
compared to its alphavirus relatives. The rubella capsid protein is a critical structural 
component of virions as well as a key factor in virus-host interactions. Three crystal 
structures of the structural domain of the rubella capsid protein have been described here. 
The polypeptide fold of the capsid protomer has not been observed previously. The capsid 
protein structure, along with cryo-electron tomograms of rubella virus particles and 
mutational studies on the capsid protein, provides a low resolution structure of the virus 
particle. Nucleocapsid assembly studies on the rubella capsid protein has given additional 
information on the factors affecting formation of the virion cores. Together, these studies 








CHAPTER 1. INTRODUCTION TO RUBELLA VIRUS 
1.1 Overview 
Rubella virus is the only member of the Rubivirus genus, which, together with 
alphaviruses including Chikungunya virus, Sindbis virus and Ross River virus, make up 
the virus family Togaviridae. ‘Toga’ literally means cloak in Latin. Rubella virus is a 
human pathogen that causes “German measles”, a relatively mild disease characterized by 
rashes and low-grade fever. Its symptoms include fever, rashes, joint pains and swollen 
glands. The virus spread occurs through nasal or throat secretions from infected individuals. 
It is generally mild in case of children and adults. Rubella infection has serious implications 
during the first trimester of pregnancy which results in birth defects. This condition is 
called congenital rubella syndrome (CRS). Rubella virus has only one serotype and a one-
time infection provides life-long immunity against it (Hobman and Chantler, 2007). The 
prevention of the disease has been highly successful in the United States and other parts of 
the world with the introduction of live attenuated virus vaccines since 1969 (Centers for 
Disease Control and Prevention, 2010; Hobman and Chantler, 2007). Despite these 
measures, the virus still exists as an important human pathogen (Frey, 1994). There is no 
specific treatment available for the disease. 
 Rubella virus is an enveloped, single-stranded, RNA virus. The particle diameters 
of the virions range from 600-800Å, with most of the roughly spherical virions having a 
diameter of approximately 700Å (Battisti et al., 2012a) (Figure 1.1). The virus consists of 
a 40S single-stranded positive sense RNA genome enclosed within a nucleocapsid core, 
which is surrounded by a membrane-envelope with glycoproteins embedded in it. The RV 
genome is non-segmented and has a GC content (69.5%) higher than any other known 
RNA virus (Frey, 1994). The structural proteins of the virus are formed as a polyprotein 





cleaved to give 3 proteins; the capsid protein (~32kDa), the E1 (58kDa) and the E2 (42-
54kDa) glycoproteins (Oker-Blom et al., 1984a). The RV genome also encodes two non-




Figure 1.1 Rubella virion morphology. Left: Cryo-electron microscopy image of rubella 
virions. The black arrow indicates a roughly spherical virion and the white arrow shows an 
irregular shaped virion. The inserted panel on the right-top of the image shows a cylinder-
shaped virion. Scale bar indicates 500 Å. Right: Bar graph showing distribution of rubella 





1.2 Rubella virus proteins 
1.2.1 Structural proteins 
Rubella virus capsid protein 
The rubella virus capsid protein forms the nucleocapsid which contains and interacts with 
the viral genome. The capsid protein is present as a disulphide linked dimer in the virion. 
The capsid monomer consists of 277 amino acids and has a molecular weight of about 31 
kDa. It has a high pI (iso-electric point) value of 10.6 and its amino acid sequence is rich 
in arginine and proline residues. The amino terminal region of approximately 100 amino 
acids is highly basic and interacts with the viral genomic RNA to form the nucleocapsid 
(Baron and Forsell, 1991; Frey, 1994). The amino acid region of residues 28 to 56 of the 
capsid protein binds specifically to nucleotides 347-375 of the viral RNA (Liu et al., 1996). 
Phosphorylation of capsid protein, especially Serine-46, restricts binding of RNA to the 
capsid protein. Thus, phosphorylation and de-phosphorylation of the capsid protein is 
regulated in infected cells to coincide with budding of the virus (Law et al., 2003). 
The capsid protein is synthesized along with the glycoproteins as a polyprotein 
precursor. The carboxy terminus of the capsid protein is connected to the amino terminus 
of the E2 glycoprotein by a signal peptide. This signal peptide targets both these proteins 
to the endoplasmic recticulum (ER). The E2 glycoprotein gets transported to the ER lumen 
and gets cleaved off by a host cell signal peptidase. The signal peptide remains attached to 
the capsid protein anchoring it to the ER membrane (Suomalainen et al., 1990) (Figure 






Figure 1.2 Position of the rubella virus structural proteins inside a cell. The different 
proteins are shown after post-translational cleavage, along with the signal peptides and 
transmembrane domains. The letters N and C denote the amino and carboxy terminus of 
the proteins respectively. Figure reproduced from Mangala Prasad, et al., 2013. 
 
 
 Apart from forming the nucleocapsid, interaction of the capsid protein with the E1 
and E2 glycoproteins is required for assembly and budding of the virion (Qiu et al., 1994). 
The capsid protein also has other non-structural functions in the infected host cell. The 
capsid protein has been reported to regulate the viral RNA transcription and replication 
(Chen et al., 2004). It inhibits protein translation of host-cell mRNAs by binding to the 
initiation factor PABP (Ilkow et al., 2008). The capsid protein causes dramatic changes in 
the morphology and distribution of mitochondria in infected cells (Beatch et al., 2005). It 
also inhibits mitochondrial import in infected cells (Ilkow et al., 2010). It has also been 
shown to bind to proteins such as mitochondrial matrix protein (p32), prostate apoptosis 
response (Par-4) protein and Bax, which are involved in apoptotic pathways in host cells, 
thereby influencing apoptosis mechanisms in infected cells (Beatch and Hobman, 2000; 





delay in lytic release of virus during rubella infection as compared to other RNA viruses 





Figure 1.3 Different functions of rubella capsid protein in an infected cell. Figure 
reproduced from Ilkow et al., 2010. ER - Endoplasmic reticulum, TRAIL- TNF related 






Rubella virus envelope glycoproteins 
Rubella virus contains two glycoproteins, E1 and E2, that are arranged on the 
exterior of the viral membrane. Both proteins are N-glycosylated with the E2 protein 
having O-glycosylation sites also. The rubella virus glycoproteins are class I membrane 
proteins that form heterodimers.  
The E1 glycoprotein is 481 amino acids long and is more exposed on the virion 
surface than E2. Accordingly, the E1 protein is the major antigenic determinant (Katow et 
al., 1985) on the virus. It is responsible for receptor recognition (Cong et al., 2011) and 
membrane fusion of the virus with the endosomal membranes at low-pH (Yang et al., 1998; 
Katow et al., 1988). The E1 glycoprotein binds to the recently identified receptor, myelin 
oligodendrocyte glycoprotein (MOG) (Cong et al., 2011).  
The E2 glycoprotein is 282 amino acid residues in length. It is essential for proper 
folding and maturation of the E1 glycoprotein (Garbutt et al., 1999; DuBois et al, 2013). 
E2 is not easily accessible to glycosidases (Ho-Terry and Cohen, 1980) and monoclonal 
antibodies (Pettersson et al., 1985), which implies that E2 is probably buried in the 
membrane and/or concealed by the E1 on the surface. 
 
1.2.2 Non-structural proteins 
 The non-structural proteins of rubella virus are translated as a polyprotein precursor 
from the viral genomic RNA. The polyprotein is later cleaved into two products, p90 and 
p150, through the proteolytic activity of p150’s carboxy terminal region. These two 







1.3. Virus replication and assembly 
On binding to a cellular receptor, rubella virions are internalized through receptor-
mediated endocytosis (Petruzziello, 1996). Uncoating of the virus takes place in the acidic 
environment within the endosome leading to release of viral genomic RNA into the 
cytoplasm. Replication of the viral genome and subsequent production of viral proteins in 
the infected cells causes big changes in the intracellular organelle distribution and 
organization (Lee et al. 1996). Formation of cytopathic vacuoles occurs within infected 
cells. This is a characteristic of togaviruses (Hobman and Chantler, 2007). These cytopathic 
vacuoles are derived from the lysosomes in cells and are sites for the viral replication 
complexes (Lee et al., 1994; Magliano et al., 1998). The cytopathic vacuoles are frequently 
found in association with mitochondria, the ER and Golgi stacks (Risco et al., 2003).  
 On translation, the structural polyprotein of rubella virus is transported to the ER. 
The glycoproteins E1 and E2 are transported into the ER lumen while the capsid protein 
remains attached to the cytoplasmic side of the ER membrane (Suomalainen et al., 1990). 
The structural polyprotein is cleaved into its corresponding proteins by the host cell 
signalase (Clarke et al., 1987; Oker-Blom et al., 1990). Glycosylation and other post-
translational modifications of the glycoproteins occur within the ER. The structural 
proteins subsequently accumulate in the Golgi complex, where the assembly of virion 
particles takes place. The transmembrane regions of the E2 glycoprotein contain a Golgi 
retention signal and is predicted to determine the site of virion assembly (Garbutt et al., 
1999). Interactions between the cytoplasmic domains of the glycoproteins and the capsid 
protein possibly form the trigger for virus budding (Garbutt et al., 1999; Qiu et al., 1999). 
The physical association observed between the Golgi stacks and the viral replication 
complexes form the basis for passage of the newly synthesized viral genome RNA to the 
sites of virus assembly (Fontana et al., 2010). Rubella virus-like particles can be formed 
by expressing only the structural proteins in cultured cell lines. This indicates that the 
presence of viral genomic RNA is not essential for the assembly of virions (Hobman et al., 
1994).  
 The budding of rubella virus particles occurs on the Golgi membranes. The 





virus particles (Frey, 1994). Freeze-substitution electron microscopy studies of cells 
infected with rubella virions show that the rubella virions first assemble and bud as an 
immature form of the virus. These ‘immature’ virions are uniformly dense particles. These 
later undergo morphogenesis to form the mature virus particles during its passage through 
the Golgi. The mature virion particles are then secreted out of the cells through the trans-






1.4 Comparison between the Togavirus genera 
 Togaviruses are enveloped, positive-sense, single-stranded RNA viruses. The two 
genera under this family are the alphaviruses and the rubivirus. The rubivirus genus has 
only one member, the rubella virus. The alphavirus genus, on the other hand, includes a 
diverse class of viruses that include 26 different species. These infect both birds and 
mammals. Some of the well known alphaviruses are the Chikungunya virus, Sindbis virus, 
Semiliki forest virus, Ross River virus and the equine encephalitis viruses (Griffin, 2007).  
 Alphaviruses and rubella virus have a similar sized genome. The gene order is also 
similar (Oker-Blom et al.,1984b). Both these sets of viruses have membrane associated 
replication complexes and virus assembly sites (Strauss and Strauss, 1994; Fontana et al., 
2010). There is also significant structural similarity between the E1 glycoproteins from 
alphaviruses and rubella virus (DuBois et al., 2013). 
 Beyond these similarities, the alphaviruses and rubella virus differ on many counts. 
Though they share similar genome organization, alphaviruses and rubella virus have very 
little homology in their nucleotide or amino acid sequences (Oker-Blom et al., 1984b). 
Alphaviruses are uniformly sized, icosahedral particles whereas the rubella virions occur 
in different shapes and sizes. The alphavirus capsid protein is an auto-protease that 
assembles into nucleocapsids in the cytoplasm. The virus budding occurs at the plasma 
membrane (Strauss and Strauss, 1994). In contrast, the rubella virus capsid protein does 
not possess any protease activity and is associated with the intracellular membranes. 
Nucleocapsid assembly of the rubella virus takes place simultaneously with virus budding 








CHAPTER 2. STRUCTURE DETERMINATION OF THE RUBELLA VIRUS 
CAPSID PROTEIN 
The work described in this chapter has been accepted for publication (Mangala Prasad et 
al., PNAS, 2013 (in press)). Parts of the chapter that were taken verbatim from the paper 




 High resolution structural information on the pleomorphic rubella virus has long 
been elusive. This is mainly because the currently available high resolution techniques for 
virus studies, x-ray crystallography and cryo-electron microscopy, depend on sample 
homogeneity. Studying the individual structural components of the virus is an indirect 
method to gather information about the structure of the whole virus. 
The rubella capsid protein is a key structural protein in the rubella virion. It forms 
the inner nucleocapsid core of the virus and contains the viral RNA genome. The capsid 
protein is also known to have several other cellular functions that are required for the 
successful replication and assembly of the virus (Ilkow et al., 2010). Secondary structure 
prediction for the rubella capsid protein indicates that about 120 residues at the amino 
terminus of the protein are disordered. This disorder is similar to that in viruses such as the 
picornaviruses (Rossmann and Johnson, 1989) and alphaviruses (Cheng et al., 1995; 
Mukhopadhyay et al., 2006), in which the amino termini of the capsid protein are 
disordered and interact with the viral RNA. Comparison of rubella capsid protein 
secondary structure prediction with the known secondary structure of the capsid protein of 
Sindbis virus (an alphavirus) suggested that approximately 100 amino terminal residues 
are highly basic and disordered in both proteins. In alphaviruses, approximately 100 amino 
terminal residues of its capsid protein are associated with viral RNA (Geigenmuller-Gnirke 






also, the structural unit is formed by the carboxy terminal fragment of its capsid protein  
The atomic structure of the capsid protein may help to gain some information on 
the molecule and its arrangement in the nucleocapsid core. It might also help to explain the 
diverse functions attributed to the protein. 
To obtain the high resolution structural information on the rubella capsid protein, 
x-ray crystallography has been used. In this technique, an x-ray diffraction pattern obtained 
from the protein crystal is utilized to determine the arrangement of atoms in the protein 
structure. To obtain structural information, both intensities and phases of the diffracted x-
rays are required. X-ray diffraction data of a protein crystal gives only the intensity 
measurements of the diffracted x-ray spots. To obtain phase information, different methods 
such as Molecular Replacement, Multiple Isomorphous Replacement and Multiple 
wavelength Anomalous Dispersion are used.  
 
2.1.1 The Molecular Replacement method (MR) 
The MR method can be used to obtain trial phases for an unknown protein structure 
if a suitable atomic model is available (Rossmann and Blow, 1962). This may be any other 
protein or part of it with a similar structure to the protein of interest. This method consists 
of two major steps, the rotation function and the translation function. The rotation function 
is used to determine the orientation of the structure in the unit cell by super-imposition of 
the Patterson function of the known structure model with the Patterson function of the 
unknown structure.  
A Patterson function is a mathematical function with a form similar to the electron 
density function, but with phases as zero. The peaks in this map denote the inter-atomic 
vectors between atoms in the unit cell (see McPherson, 2003). Thus, when the relative 
orientation of the structure model is similar to the unknown structure in the crystal unit 









Mathematically, the rotation function (R) can be expressed as (Rossmann and 
Blow, 1962): 
R = Σ [|Fh|
2 {Σ|Fp|
2 G}] 
where Fh and Fp are the structure factor amplitudes of the unknown structure and the model 
respectively. G is an interference function which has large values only when the position 
of a reciprocal lattice point ‘p’ corresponding to the model structure is brought close by 
rotation to the position of reciprocal lattice point ‘h’ corresponding to the unknown 
structure. 
 
 Once the orientation of the molecule is determined, the translation function is used 
to place the model at a position in the unit cell that best fits the observed data. Different 
methods can be used for this calculation. Typically, many of these methods are Fourier 
methods. The Phaser program uses the Maximum Likelihood Translation function (McCoy, 
2005). 
 
2.1.2 The Multiple Isomorphous Replacement method (MIR) 
 The MIR technique involves using native crystal diffraction data along with 
diffraction data from different isomorphous heavy atom derivatives of the native protein to 
determine protein structures. This technique was used to determine the first protein 
structures, myoglobin (Kendrew et al., 1960) and hemoglobin (Perutz et al., 1960), which 
marked the start of the protein crystallographic era.  
Heavy atom derivatives of protein crystals can be obtained either by soaking the 
crystal or co-crystallization of the protein with heavy atom compounds. A difference 
Patterson map between the structure factor amplitudes of native and derivative data can 
then be used to obtain the position of the heavy atoms. The heavy atom positions can be 
used to calculate their corresponding phases.  
Assuming that the presence of a heavy atom does not change the structure of the 






as a vector sum of the structure factors of the native crystal (FP) and the heavy atom (FH) 
(see Ladd and Palmer, 2003):  
FPH = FP + FH 
where bold characters indicate vectors. 
 
The above equation can be represented graphically as in Figure 2.1. 
 
Figure 2.1 Graphical representation of the isomorphous replacement equation. The 




Using the structure factors of the heavy atom, the phases for the protein structure 
can be calculated. This can be represented geometrically using the Harker diagram (Harker, 











Figure 2.2 Harker diagram using two heavy atom derivatives. The circle denoted as FP 
is drawn using the origin as centre with a radius equal to the amplitude of the native protein 
structure factor. The circles denoted F1 and F2 are drawn with radius equal to the amplitude 
of the respective heavy atom derivative protein structure factors. However, the centres for 
these circles are at the end of the vector for their respective heavy atom structure factors 
(H1 and H2). The point at which the three circles co-incide gives the phase angle for the 
protein structure factor. 
 
 
 As can be deduced from the above descriptions, isomorphous replacement can also 
be done with only one heavy atom derivative for the protein. In this case, an ambiguous 
result for the phase angle is obtained. This can be seen from the Harker diagram (Figure 
2.2). If there is only one derivative, there will only be two circles in the diagram, which 
will result in two positions of intersection between them. The correct phase angle then 
needs to be determined by testing the different solutions. Another solution for finding the 
correct phase angle would be to use the anomalous scattering from the heavy atoms to 












(Single isomorphous replacement with anomalous scattering). The concept of anomalous 
scattering is explained in detail in the next section. 
 
2.1.3 The Multiple Anomalous Disperson method (MAD) 
 The MAD method is most useful when the native protein crystal and the heavy 
atom derivative protein crystal are non-isomorphous. MAD datasets are also collected on 
heavy atom derivative crystals, but at different wavelengths. The MAD method exploits 
the anomalous scattering property of heavy atoms. 
All elements absorb x-rays. The absorption increases with increasing atomic 
number of the element. For every element, there is an energy value when the energy of the 
x-ray radiation is sufficient to eject an electron from a specific electron shell in its atom. 
This point is called the element’s absorption edge. When x-rays at wavelengths close to 
the absorption edge of an atom are used, the scattering by the atom becomes anomalous. 
Anomalous scattering of an atom introduces changes in the phase of its atomic scattering 
factor. The atomic scattering factor (f) can now be expressed as a complex number 
(Rossmann, 1961):  
f = f0 + Δf’ + i Δf’’ 
where f0 is the wavelength independent scattering factor and f’ and f’’ are the two 
wavelength-dependent scattering factors. The Δf’ and Δf’’ values can be calculated for a 
specific atom based on the energy of the x-ray wavelength used. 
Thus, at the absorption edge, an atom’s diffraction spectra no longer follows 
Friedel’s law. Friedel’s law can be simply stated as (see Ladd and Palmer, 2003): 
|F(h, k, l)| = |F(-h, -k, -l)| 
where F is the amplitude of the structure factor of the diffraction spot and (h, k, l) denotes 
the position of the spot in reciprocal space. 
 A Pattersson synthesis with coefficients as the square of the difference between the 






(Rossmann, 1961). Phases for the heavy atoms can then be calculated and subsequent trial 
phases for the native protein data obtained. 
 
Once the phases are obtained using any of the techniques described above, an 
electron density map can be calculated using all reflections and an atomic model built to 
fit the electron density. Iterative refinement procedures can then be used to improve the 









 The nucleotide sequence encoding the full length rubella capsid protein derived 
from the rubella virus strain M33 was provided as a pET23 plasmid construct (Ilkow et al., 
2008) by Dr. Tom Hobman, University of Alberta, Canada. This sequence was used for 
subsequent cloning of the capsid protein into various other constructs. 
 Full length and truncated forms of the rubella capsid protein were cloned into 
pET28a (Novagen) and pGEX-KG (ATCC-77103) vectors. The pET28a vector encodes 
for amino and carboxy terminal His tag. The pGEX-KG vector encodes for a Glutathione 
S-transferase (GST) tag at the amino terminus of the protein of interest. Preparation of the 
plasmid constructs was carried out using standard cloning protocols provided in the pET 
system manual (Novagen). Briefly, the DNA sequence of the desired protein length was 
amplified through polymerase chain reaction (PCR) with the addition of suitable restriction 
endonuclease cleavage sites at the 5’ and 3’ end of the sequence. The amplified DNA 
fragment was then digested with two restriction endonucleases corresponding to the 
cleavage sites at the 5’ and 3’ end. This DNA fragment or insert was then ligated into the 
similarly digested plasmid vector. The ligation mixture was transformed into Escherichia 
coli (E.coli) Novablue competent cells (Novagen). Colonies were selected using the 
antibiotic resistance conferred by the vector.  Colonies positive for the desired clone were 
confirmed through restriction endonuclease digestion and DNA sequencing. A list of the 
different capsid protein constructs made, along with their primer sequences are given in 













Table 2.1 List of capsid protein constructs 
Capsid protein 
length 














































1RVC denotes rubella capsid protein and N refers to the amino terminus of the protein 









2.2.2 Expression of capsid protein constructs 
The different constructs listed in Table 2.1 were tested for soluble protein 
expression in a bacterial expression system. The plasmid constructs were transformed into 
E.coli BL21 (DE3) cells (Novagen). 0.5 µl of the plasmid clone was incubated on ice with 
30-50 µl of E.coli BL21(DE3) competent cells for 10 minutes. The mixture was then heat 
shocked at 42 ºC for 1 minute and placed on ice again for further 10 minutes. 450 µl of 
Luria Bertani (LB) medium was added to the mixture and cultured by shaking at 250 rpm 
for 1 hour at 37 ºC. The cultured cells were then plated onto LB plates with the 
corresponding antibiotic for the plasmid vector used.  
Colonies were picked from the cultured LB plates and grown in 5 ml of LB medium 
at 37 ºC till an O.D of 0.6 was reached. The cultures were then induced with 1mM Isopropyl 
thiogalactoside (IPTG) at temperatures of 37 ºC, 30 ºC, 25 ºC and 16 ºC for time durations 
of 2, 4, 6 and 16 hours respectively. The cells were pelleted and lysed using Bugbuster 
master mix solution (Novagen) for 20 minutes at room temperature. The cell lysate was 
centrifuged at 15000 rpm for 10 minutes to obtain a clarified supernatant and pellet. The 
supernatant and pellet fractions were analyzed using SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) to determine the expression and solubility of the capsid 
protein constructs. 
   
2.2.3 Large-scale protein expression and purification 
 Soluble expression of the capsid protein construct with amino acid residues 127-
277 fused with an amino terminal GST tag was observed in the protein expression tests. 
Henceforth, this clone will be denoted as RVC-N127-277-GST. For large scale expression, 
the cells containing the plasmid for RVC-N127-277-GST were grown in 1 liter LB medium 
at 37 °C. Expression of the fusion protein was induced when the culture O.D reached 0.6 
with 1 mM IPTG. The induced cultures were grown at 25 °C for 6 hours before harvesting 
the cells. The cells were pelleted by centrifugation at 6000 rpm for 15 minutes at 4 °C. The 
cell pellets were re-suspended in phosphate buffer saline (PBS, pH 7.4) and lysed in ice 
using a sonicator. The lysed cells were centrifuged at 15,000 rpm for 25 minutes using a 






Lifesciences) under constant stirring for 1 hour at 4 °C. The supernatant with the beads was 
then packed into a 5 ml chromatography column. The column was washed with 5 column 
volumes of PBS. The GST beads with the fusion protein were then incubated with 50 units 
of thrombin (GE Lifesciences) overnight at room temperature. Cleaved rubella capsid 
protein was collected as flow-through from the beads. The GST tag bound to the beads was 
eluted using 5 column volumes of 20 mM reduced Glutathione in 100 mM Tris, pH 8.0. 
The previously collected flow-through from the GST column was further purified using a 
Superdex 75 gel filtration column (GE Lifesciences). The elution fraction containing the 
capsid protein was collected and concentrated to 5 mg/ml. The yield of the purified protein 
was approximately 0.25 mg/ml  
 
2.2.4 Large scale purification of Selenomethionine (Se-Met) derivatized capsid protein 
The RVC-N127-277-GST protein was produced as a Se-Met derivatized protein 
similar to the protocol outlined in VanDuyne et al., 1993. The E.coli BL21(DE3) cells were 
transformed with the plasmid clone and grown overnight in 50 ml of LB medium at 37 ºC. 
The cells were pelleted and added to M9 minimal medium (6 g/l Sodium phosphate dibasic, 
3 g/l Potassium phosphate monobasic, 1 g/l ammonium chloride and 0.5 g/l sodium 
chloride in distilled water). The culture was grown at 37 ºC till an O.D of 0.3 was reached. 
Se-Met and other amino acids were then added to the culture. Fifteen minutes later, over-
expression of protein was induced with 1 mM IPTG at 25 ºC. The cells were grown for 6 
hours and harvested. The target protein was purified with the same procedure as the native 
protein (Section 2.2.3). 
 
2.2.5 Crystallization and data collection 
 Crystallization trials were set-up using Hampton crystallization screen-kits. Initial 
crystals of the capsid protein were obtained as clusters of thin plates in 50 mM HEPES at 
pH 7.5, containing 10% 2-propanol and 25% PEG-4000. This crystal condition was then 
optimized by varying the buffer, 2-propanol and PEG-4000 concentrations. The Se-Met 
protein crystallized in similar conditions as the native protein. These crystals formed 






crystals after two months of setting up the crystallization condition. After extensive 
screening, thin-plate crystals of rubella capsid protein were also obtained in the presence 
of 50 mM Bis-Tris at pH 6.5, 200 mM NaCl, 25% PEG-3350 and 1% LDAO (lauryl-
dimethylamine oxide).  
For phase determination, crystals were tested with different heavy atom compounds 
through co-crystallization or soaking. The different heavy atoms that were tested include 
mercury, platinum, iodine, gold, lead, elements of the lanthanide series and uranium. Co-
crystallization trials were set-up at heavy atom compound concentrations of 2-5 mM in the 
crystallization drop. For soaking experiments, heavy atom compounds were added to the 
crystals at different concentration ranges (1 mM-10 mM) for different lengths of time (20 
minutes to 1 day). 
All crystals were screened at the Advanced Proton Source, GM/CA, beamline 23 
ID-D and ID-B, Chicago, USA.  
 
2.2.6 Structure determination and refinement 
 The diffraction data obtained from the different crystal forms of the rubella capsid 
protein were indexed, integrated and scaled using HKL2000 (Otwinowski and Minor, 
1997). The output intensity files were converted to structure factor files using the CCP4i 
program package (1994).  
 Based on sequence comparisons, the rubella capsid protein does not have any 
homologues in the NCBI protein database. However, by functional similarities and 
grouping of rubella virus with alphaviruses, the Sindbis virus capsid protein structure was 
used as a molecular replacement model for the rubella capsid protein structure 
determination. The Phaser program (McCoy, 2007) from the CCP4i package was used for 
these trials. 
 Crystals soaked with heavy atom compounds were used to collect diffraction data 
at different wavelengths for MAD and MIR trials. Datasets from various heavy atom 
soaked crystals were analyzed for the presence of anomalous signal. Unmerged datasets of 
the heavy atom derivative crystals were analyzed by comparing the absolute difference 






the non-centric reflections. Higher differences in amplitudes between friedel pairs of the 
non-centric reflections when compared to the centric reflections indicated the presence of 
anomalous scatterers (heavy atoms) in the crystal.  
 SIRAS was used to determine initial phases from the uranium-soaked protein 
crystal datasets. This was carried out using the Autosolve program (Terwilliger et al., 2009) 
in the Phenix software package (Adams et al., 2010). The heavy atom parameters were 
determined at 3.7 Å resolution and the initial phases were calculated at 3 Å resolution. An 
electron density map was calculated using Phenix.solve (Terwilliger, 2003). The map was 
then solvent flattened and averaged using non-crystallographic symmetry (NCS) detected 
by Phenix.resolve (Terwilliger, 2003). The initial protein chain was built into the electron 
density map manually using COOT (Emsley and Cowtan, 2004) and further refined using 
Phenix.refine (Afonine et al., 2012). The refined map was then used to further build and 
correct the initial protein chain. This procedure was used iteratively till all the electron 
density in the map could be interpreted.   
 The above structure was used as a molecular replacement model to determine the 
structures in the other crystal forms obtained for the capsid protein. The procedure was 






2.3 Results and Discussion 
2.3.1 Expression and purification 
 The different constructs of the rubella capsid protein were tested for soluble protein 
expression. Of all the conditions tested, soluble capsid protein expression was obtained 
only for the clones RVC-N127-277-GST and RVC-N148-277-GST at 25 ºC for 6 hours on 
induction with 1 mM IPTG. Thus, the longest soluble construct only accounted for 
approximately 2/3rd of the whole capsid protein length. 
 Based on the expression tests, RVC-N127-277-GST was used for further 
purification and crystallization trials as it was the longest capsid construct. The RVC-
N127-277-GST clone was expressed in E.coli BL21(DE3) cells. The fusion protein was 
purified using GST affinity chromatography and cleaved with thrombin to give the rubella 
capsid protein. The cleaved protein was further purified using gel filtration 
chromatography. The rubella capsid protein eluted as a single peak at an elution volume 













Figure 2.3 Gel filtration chromatography profile of the recombinant rubella capsid 
protein. The y-axis is the UV absorption measurement at 280 nm (mAU) and the x-axis is 
the elution volume (ml). Based on the standardized elution profile for Superdex 75 16/600 
prepgrade (GE Lifesciences), the capsid protein peak has an apparent molecular weight of 
~40 kDa which indicates that the protein forms a dimer in solution. The molecular weight 
of the capsid monomer is 17 kDa. The two smaller peaks in the elution profile are un-
identified protein impurities in the sample. 
 
 
2.3.2 Crystallization, data collection and processing 
The first crystals of the truncated rubella capsid protein were obtained as clusters 
of thin plates in 50 mM HEPES pH 7.5, 10% 2-propanol and 20% PEG-4000. Improved 
crystals were obtained in 50 mM Tris pH 7.5, 24% 2-propanol and 25% PEG-4000 (Figure 
2.4). Thin plates were broken from the clusters and used for data collection. The crystals 










Figure 2.4 Thin cluster crystals of rubella capsid protein. These crystals were obtained 
in 50 mM Tris pH 7.5, 24% 2-propanol and 25% PEG-4000. 
 
 
Cuboidal shaped crystals of Se-Met derivatized capsid protein (Figure 2.5) 
diffracted to 3.25 Å and had space group C2221with five molecules in the asymmetric unit. 
These crystals were non-isomorphous with the native crystals. A Patterson function using 
the Se-Met crystal dataset had large non-origin peaks at (0,1/5,0) that were about 50% of 
the height of the origin peak. Thus, this crystal form had pseudo-translational symmetry 
(Figure 2.6). Analysis of the structure factor amplitudes showed that all reflections with a 
Miller index, k, divisible by 5 were much larger than other reflections, indicating that the 
actual unit cell was approximately divided into five smaller unit cells that repeat the 
structure in the b (axis) direction. Each of these smaller unit cells had a C2221 space group, 
but with only one molecule in the asymmetric unit. Although the Se-Met RV capsid protein 
crystal showed anomalous signal, it was very weak. 
Automated phasing program packages, Phenix and CCP4, were unable to locate 
heavy atom sites in the Se-Met dataset due to the weak anomalous signal of the Se atoms 
and the strong pseudo-translational symmetry. Manual interpretation of peaks in the Harker 
sections of the anomalous difference Patterson maps were used to identify 1 heavy atom 
site per protein molecule.  
Though there were two methionine residues per protein molecule, only one Se site 
was identifiable with confidence. The other site may have been disordered in the crystal. 






factors of the friedel pairs for a given reflection, to determine initial phases. However, the 
phases obtained were not accurate enough to produce an interpretable electron density map. 








Figure 2.6 Native Patterson map generated map section from the Se-Met capsid 
protein derivative data. The section shown is of the x-y plane at z = 0, where x,y,z are 
the Cartesian axes. The section divisions are in fractional co-ordinates. 
 
 
Thin-plate crystals were obtained in PEG-3350 (Figure 2.7) and were found to 
diffract inconsistently with best diffraction to 2.66 Å resolution. The space group of these 








Figure 2.7 Thin plate crystals of rubella capsid protein in PEG-3350. 
 
 
Rotation function analysis was used to determine the non-crystallographic 
symmetry between the six molecules in the asymmetric unit (Tong and Rossmann, 1997). 
A rotation function depends on multiplying the crystal’s Patterson function with its rotated 
version. The rotation is represented by a set of polar (φ, ψ, κ) angles. The angles φ and ψ 
define the orientation of a rotation axis relative to a Cartesian coordinate system and κ 
defines the angle of rotation around this axis.  
In the self-rotation functions shown below (Figure 2.8), the radius of integration 
was 25 Å, and the resolution range was between 4-12 Å. The radius of integration specifies 
the integration volume for the rotation function. An optimum value for the radius of 
integration will exclude vectors between atoms from molecules outside the asymmetric 
unit of the crystal. All peaks shown have values three standard deviations above the mean 
intensity values (sigma). On analysis, the prominent peaks in the self-rotation function for 
this dataset corresponded to peak patterns observed in objects with octahedral symmetry. 
However, when the structure had been determined, it was discovered that the molecular 
arrangement in the crystal did not exhibit any octahedral symmetry. Hence, the presence 
of self-rotation peaks exhibiting octahedral symmetry was evidently an artifact of crystal 

















Figure 2.8 GLRF analysis. A. Octahedron showing the symmetry axes. B-D. Self-rotation 
function plots at κ values of 180°, 120° and 90° respectively. The radius of integration is 
25 Å. The resolution range is 12-4 Å. The contour levels range from one to ten sigma with 
a step size of 0.4 sigma. All peaks shown have values three sigma and above. The Ψ angles 
are denoted by the latitudinal lines and marked 0° to 180° along the perimeter of the sphere. 
The Φ angles are denoted by the longitudinal lines on the surface of the circle. Each 

























B. Two-fold rotation axis  






C. Three-fold rotation axis 





The C2 space group crystals were soaked in 2 mM uranium nitrate hexahydrate 
(UO2(NO3)2.6H2O) overnight at room temperature. The crystals soaked in the uranyl 
compound diffracted to 3.7 Å resolution. A single wavelength anomalous dispersion (SAD) 
dataset was collected from these crystals. The uranyl compound-soaked crystal data was 
isomorphous to the native crystal and was used for determination of heavy atom sites.  
 
2.3.3 Structure determination and refinement 
The determination of the heavy atom parameters and subsequent phasing was 
performed with the phenix.autosol software. Phases were improved by density 
modification using non-crystallographic symmetry with the same program. The initial 
protein chain was built into the electron density map manually using COOT (Figure 2.9) 
and refined using Phenix.refine. The refined map was then used to further build and correct 
the initial protein chain. This procedure was used iteratively till all the electron density in 
the map was interpreted. The uranyl moiety was found to be interacting with Glu-229, Arg-
230, Asp-231 and His-240 in each of the six RV capsid proteins in the asymmetric unit. 
Parts of the protein that seem to be disordered include the 30 amino acids of the carboxy 
terminal end and approximately 20 amino acids of the amino terminal end. The protein 
chain that could be built extended from residue 151 to 247 (Figure 2.10). 
 
 










Figure 2.10 RV capsid protein secondary structure. Amino acid sequence (127-277) 




The structures of RV capsid protein in the P22121 and C2221 space groups were 
determined by MR using the Phaser software. Refinement of the structure in the C2221 
space group had some difficulty due to the strong pseudo-translation symmetry in the 
crystal. The problem was to differentiate the small differences in structure between the five 
slightly different molecular positions in the five very similar smaller cells. Whereas the 





overall structure was given by the strong reflections when the Miller index k was divisible 
by 5, the other weak reflections determined the differences between the different sub-unit 
cells. At the completion of refinement, the R factor for the strong k/5 reflections was 26% 
and for the other weak reflections it was 39%. 
The crystallographic data and refinement statistics are given in Table 2.2. 
 
 
Table 2.2. X-ray data and crystallographic information 
 
 
Crystal RVC1 –  
Native-1 
Crystal RVC1 –  
Native-2 
Crystal RVC1 –  
Se-Met derivative   
Data collection 
X-ray wavelength (Å) 1.006 1.072 0.988 
Space group P22121 C2 C2221 
Cell dimensions      
a,b,c (in Å ) 37.73, 71.48, 79.04 147.76, 74.78, 96.07 42.79, 279.7, 76.73 
α,β,γ (in degrees) 90, 90, 90 90, 97.529, 90 90, 90, 90 
Resolution (Å)2 2.28 (2.32– 2.28) 2.66 (2.71 - 2.66) 3.25 (3.31 - 3.25) 
Rmerge2 0.082 (0.441) 0.08 (0.428) 0.061(0.522) 
I/ΔI2 21.09 (2.26) 26.71 (5.58) 14.27 (3.74) 
Completeness (%)2 95.6 (99.4) 100 (86.9) 99.1 (92.7) 
Overall Redundancy 8.1 6.7 12.7 
Refinement 
No. of reflections 9961 29202 13688 
Rwork/Rfree 0.199/0.258 0.185/0.23 0.339/0.367 
Ordered residues 150 – 247 150 – 250 150 – 246 





Table 2.1 Continued 
R.m.s deviations 
Bond length (Å) 0.008 0.008 0.007 
Bond angles (deg.)  1.23 1.34 1.197 
Ramachandran plot (%) 
Favored 93.8 97.2 80.7 
Allowed 6.2 2.5 13.5 
Outliers 0 0.3 5.8 
1 Rubella virus capsid protein (RVC) 
2 Numbers in parentheses represent values in the highest resolution shell 
 
 
2.3.4 Structure of the rubella virus capsid protein 
The structure of each monomer of the rubella capsid protein structural domain 
consists of five anti-parallel β-strands A, B, C, D, E as well as a two turn α-helix H between 
strands B and C (Figure 2.11). The strands and helix are connected by loops AB, BH, HC, 
CD and DE. The BH loop is by far the largest loop consisting of residues 176 to 197. 
Although the core structure (missing the BH loop) of each of the thirteen independent RV 
capsid monomers from the three different crystal forms are essentially the same (Table 
2.3), the BH loop structure is different in each of the crystal forms (Figure 2.11) and is 










Figure 2.11 Rubella capsid monomer structure. Left: Ribbon diagram of the capsid 
monomer. The β-strands are marked A to E, starting from the N-terminus. The α-helix is 
marked as H. Right: Superimposed ribbon diagrams of the monomer as seen in the C2 
(cyan) and P22121 (magenta) crystals. 
 
 
Table 2.3 Root mean square difference (RMSD) (in Å) between Cα atoms in the core 





























0 0.07 0.07 0.07 0.06 0.13 0.53 0.40 0.49 0.99 0.83 0.76 0.64 
mC-
B 
 0 0.08 0.06 0.06 0.13 0.51 0.40 0.48 0.99 0.82 0.77 0.64 
mC-
C 
  0 0.07 0.05 0.15 0.49 0.38 0.46 0.64 0.84 0.78 0.67 
  





Table 2.3 Continued 
mC-
D 
   0 0.07 0.11 0.51 0.40 0.47 0.98 0.81 0.76 0.63 
mC-
E 
    0 0.14 0.50 0.39 0.47 0.63 0.83 0.77 0.66 
mC-
F 
     0 0.51 0.39 0.47 1.0 0.77 0.77 0.64 
oP- 
A 
      0 0.53 0.37 0.34 1.10 1.08 0.42 
oP- 
B 
       0 0.43 1.07 1.03 0.98 0.96 
oC- 
A 
        0 0.85 1.48 0.95 1.16 
oC- 
B 
         0 1.13 0.52 1.07 
oC- 
C 
          0 1.43 2.27 
oC- 
D 
           0 0.42 
oC- 
E 
            0 
1The different crystal structures are identified by the space group of the crystals in which 
they occurred (mC for monoclinic C centered, oP for orthorhombic primitive, oC for 
orthorhombic centered) and chain names (A, B etc.). The RMSDs were calculated using 
the Homology software (Rossmann and Argos, 1976). 
 
 
All three crystal forms indicate that the RV capsid protein forms a 2-fold symmetric 
dimer. The monomers are associated by disulfide bonds between Cys-153 and Cys-198. 
Within a dimer the β-sheet is continuous with the residues 170-176 of β-strand B from one 





monomer being hydrogen bonded with the same but anti-parallel β-strand B in the other 
monomer. The resultant ten-stranded, left-handed twisted sheet forms a partially open β-
barrel with the two helices lying in the center of the barrel. The β-strands A and B from 
one monomer are inserted into the BH loop of the other monomer, forming a tightly bound 
dimeric structure (Figure 2.12). A DALI search (Holm and Rosenstrom, 2010) using the 




Figure 2.12 Ribbon diagram of the RV capsid protein dimer. The two figures are 180° 
related to each other. The black oval shape (q2) indicates a quasi-two-fold axis. The 
monomer chains are represented in cyan and magenta. 
 
 
In the P22121 crystal structure, there is a one residue translation in β-strand C, at the 
edge of the β-sheet, with respect to strand D in one of the monomers (Figure 2.13). This 
translation requires a 180º flip of the peptide bonds in the C strand. A variety of tests were 
conducted to confirm these unexpected amino acid assignments. The presence of Trp, Arg 
and Lys residues in the C β-strand helped to confirm the correctness of the structure. The 
impact of this change was not as large as might have been expected because the two basic 
residues are oriented in the plane of the sheet rather than being perpendicular to the sheet. 
 






Figure 2.13 Diagram of the capsid dimer structure as seen in the P22121 crystal form. 
Bold letters are names assigned to the secondary structural elements, the letters in the 
magnified C and D β-strands refer to amino acid abbreviations. 
 
 
 All three crystal forms of the RV capsid protein contain rows of closely packed 
dimers (Figure 2.14) in which neighboring dimers are held together by hydrogen bonds 
and hydrophobic contacts. The interactions between rows are fewer and formed mostly by 
hydrophilic contacts. In the C2 crystal form, adjacent dimers in a row make hydrophobic 
contacts between Trp-221 in one dimer with Trp-189 andPro-191 in the neighboring 
dimer's BH loop. In the C2221 crystal form, the dimers interact through hydrogen bonds 
between the terminal β-strands C (amino acids 218-222) in neighboring molecules. In the 
P22121 crystal form, the dimers are organized into a staggered row-like arrangement similar 
to that in the C2221 crystal form and also involve hydrogen bond interactions between Val-
220 of one monomer with Gly-219 of the neighboring monomer. The similar rows of 
dimers in the P22121 and C2221crystal forms have a surface that is mostly positively 












2.3.5 Orientation of the Capsid Protein in the Virion 
In infected cells, the carboxy terminus of the RV capsid protein remains attached 
to the E2 signal peptide which anchors this viral protein to intra-cellular membranes 
(Suomalainen et al., 1990). This implies that, the carboxy terminus of the RV capsid 
structure should be oriented towards the membrane surface in the virions. Hence, the 
optimum way to orient the dimer structure would be for the dimer axes to be perpendicular 
to the membrane, thus placing the carboxy termini of the monomers at approximately equal 
distances from the membrane (Figure 2.14C). The distance to the end of the E2 signal 
peptide in the membrane can then be easily spanned by the disordered 27 amino acids at 
the carboxy termini of the capsid protein dimer. As the amino terminal region of the RV 
capsid protein interacts with the viral RNA (Hobman and Chantler, 2007), placing the 
dimer axis perpendicular to the membrane would also position the exposed amino terminus 



















Figure 2.14 Rows of RV capsid protein dimer. Rows in the crystal forms (A) C2, (B) 
P22121and (C) C2221 with dimer axis parallel and perpendicular to the plane of the paper, 
respectively. For each crystal form, the molecular surface that presumably faces the viral 
membrane is shown, colored according to its electrostatic potential. The potentials (Baker 
et al., 2001) at 300K are in the range +125 mV (+5 kT/e) (blue) to -125 mV (-5 kT/e) (red), 
where k = Boltzmann’s constant, T= temperature, e = electronic charge and mV = millivolts. 
The dotted lines (q2) correspond to quasi-two-fold axes. Figure panels were prepared using 


























2.3.6 Location of the Glycoprotein Binding Region on the Capsid Protein 
In alphaviruses the glycoproteins have a cytoplasmic domain that is anchored in the 
nucleocapsid (Mukhopadhyay et al., 2006). Similarly, in RV the short predicted 
transmembrane and/or cytoplasmic domains of the RV E2 glycoprotein may serve as an 
anchor on the capsid protein (Garbutt et al., 1999). The cytoplasmic domain of E2 has been 
shown to be essential for budding of RV into the Golgi apparatus (Garbutt et al., 1999). In 
the C2 crystal structure, three detergent molecules derived from the crystallization solution, 
are associated with each capsid monomer. It is possible that this binding site in the RV 
capsid functions similarly to the pocket in alphavirus capsid proteins that interact with the 
carboxy terminal region of E2 (Lee et al., 1996). The binding site for the detergent 
molecules in the RV capsid protein consists of mostly hydrophobic residues and a few 
conserved acidic residues. Appropriately, the carboxy terminal cytoplasmic region of the 
RV E2 protein contains mostly positively, highly conserved, charged residues that 
complement the binding site. However, this site is only occupied in the C2 crystal form, as 
this is the only form in which there is a suitable ligand in the crystallization solution that 
might bind into the pocket. 
 





2.4. Evolution of the Viral Structural Proteins 
Although the core structure of the RV capsid protein is the same in all the crystal 
forms reported here, there is variability in the relative positions of the secondary structure 
elements in the different crystal structures (Table 2.3). This variability indicates flexibility 
in the capsid protein structure which may be required for its numerous cellular functions 
(Ilkow et al., 2010b) by facilitating its interaction with a large cohort of host cell proteins 
such as Bax, mitochondrial matrix protein p32, prostate apoptosis response protein and 
poly(A) binding protein. . However the RV capsid structure has not yet yielded any detailed 
insight into the mechanisms of its cellular functions, but its function as a viral capsid 
protein provides fascinating insight into the evolution of virus structure.   
The E1 glycoprotein of alphaviruses and RV (DuBois et al., 2013; Lescar et al., 
2001) as well as the E glycoprotein of flaviviruses (Rey et al., 1995) have similar structures. 
This common surface glycoprotein motif suggests that these structures evolved from an 
ancestral structure (DuBois et al., 2013) that can attach to potential host cells and initiate 
infection by fusion with the host cell. In contrast, the capsid protein structures of alpha-, 
flavi- and rubella viruses are completely different. The alphavirus capsid protein is a β-
sheet structure with a chymotrypsin-like fold (Choi et al., 1991) which forms an 
icosahedral shell around the viral genome, whereas the flavivirus capsid protein is an α-
helical structure (Ma et al., 2004) which is closely associated with the genome but does not 
form a protective shell. The RV capsid protein structure as reported here has a polypeptide 
fold that is different to both alpha- and flaviviruses. The common function of the capsid 
proteins in these viruses is to neutralize the charge on the genome, but the task of confining 
the genome is most obvious for alphaviruses, less clear for RV, and absent for flaviviruses. 
In addition, the capsid proteins of these viruses have gained other cellular functions that 
facilitate virus replication and assembly inside host cells. These observations show that the 
ability to attach and fuse with potential host cells has been conserved in the glycoproteins 
of these viruses while the capsid proteins have evolved independently, resulting in 







CHAPTER 3. CRYO-ELECTRON TOMOGRAPHY OF RUBELLA VIRUS 
PARTICLES 
The work described in this chapter has been accepted for publication (Mangala Prasad et 
al.(in press)). Parts of the chapter that were taken verbatim from the paper are marked by 




Cryo-electron tomography is an electron microscopic technique in which a three 
dimensional structure of an object can be determined by obtaining sequentially tilted two 
dimensional images. This technique is useful for studying samples which are 
heterogeneous as it does not require averaging between particles. However, cryo-electron 
tomography is still a relatively low resolution tool when compared to single-particle cryo-
electron microscopy and x-ray crystallography for studying biological macromolecular 
complexes. 
To obtain a cryo-electron tomogram, tilt-series images are obtained of biological 
samples frozen in vitreous ice (Figure 3.1). Images are generally taken around a single 
axis of the specimen stage, though dual-axis tilts are also possible (Iancu et al., 2005). The 
tilt-series images are then aligned with the help of fiducial gold markers that are added 
during sample preparation. A three-dimensional reconstruction of the sample can then be 






                                
Figure 3.1 Tilt-series image collection for cryo-electron tomography. Figure modified 
from Grunewald et al., 2003. 
 
 
The possibility of generating a three-dimensional (3D) reconstruction from two-
dimensional (2D) projections of the object is given by the projection theorem. According 
to this theorem, “the 2D Fourier transform of a projection of an object is identical to a 
central section of the object’s 3D Fourier transform”. Thus, by obtaining images of an 
object at different tilt angles, the entire Fourier transform of the object can be measured. 
The weighted back projection method is one of the most commonly used methods for cryo-
electron tomographic reconstructions. It works on Fourier transform data and real space 
data of the object or its projections (Frank 2006). As a first step in this method, the 







A back projection body bi of a projection pi along the direction z in the xyz plane 
can be given as,  
bi (x,y,z) = pi (x,y)q(z) 
where q(z) is 1 within a given boundary radius and 0 otherwise. In general, the boundary 
radius of the back-projection volume is at least twice the object radius.  
Summing up multiple back-projection bodies from different angles will result in a 
three-dimensional volume that resembles the object of study. This can be expressed as, 
b(x,y,z) = Σ bi (xi,yi,zi) 
where i is the ith projection in a set of projections. 
For more accurate rendering of the object, the back projected volume needs to be 
corrected using a weighting function. For a tilt series about a single axis taken at regular 
angular intervals, the correction can be applied to the Fourier amplitudes of the back-
projections by multiplication with a weight factor W. This factor can be calculated as the 
radius of the back-projection in Fourier space perpendicular to the tilt axis. 
Though, cryo-electron tomography has its merits for studying macromolecular 
assemblies that are not homogeneous, it also has some serious limitations. The highest 
resolution achievable through cryo-electron tomography is about 40Å without any sub-
tomogram averaging. Biological samples are sensitive to electron dose. As the same 
specimen is exposed to electrons at different tilt angles in tomography, the electron dosage 
per image has to be kept minimal to avoid radiation damage of the sample. Typically, the 
total electron dose per tilt-series is kept below 200 electrons/ Å2 (Tocheva et al., 2010).This 
results in low signal to noise ratio in the images. Higher defocus values are then needed to 
improve contrast in the images, which in turn affects the final achievable high resolution 
in the three-dimensional reconstruction. 
Another issue is the physical limitations of sample holders in currently available 
microscopes that allow tilt angle ranges of only ± 70º. This results in a ‘missing wedge’ of 
data that causes smearing of the reconstructed volume in the direction perpendicular to the 






quality of the images obtained. As the distance for the electron path through the sample 
increases with tilt, the likelihood of an inelastic scattering of electrons increases. Inelastic 
scattering of electrons refers to a loss of energy of the electrons on interacting with the 
specimen while passing through the microscope lens system. Thus, inelastically scattered 
electrons have a different trajectory as compared to the elastically scattered electrons and 
can confuse the acquired image (Coslett, 1978). However, the invention and use of energy 
filters has greatly helped to correct aberrations in images taken at high tilt angles. An 
energy filter is a magnetic prism that can alter the path of electrons based on their energy. 
Thus, the electrons with energy in the desired range can be selected and used to form an 
image (Schroder et al, 1990). 
For pleomorphic viruses such as rubella virus, cryo-electron tomography is the 
most viable choice to obtain a three-dimensional structure of the whole virion, albeit at low 
resolution. Tomographic studies on the rubella virus by Battisti et al.,2012a have shown 
that the rubella virion structure deviates quite markedly from that of alphaviruses. As 
opposed to the icosahedral arrangement of glycoprotein spikes on the surface of 
alphaviruses, the rubella viral glycoproteins appear as long rows of density on the virion 
surface. These rows of density are separated by 90 Å. Also, the rows of density appear to 
be paired. Based on these data, a model for the arrangement of glycoproteins on the rubella 










Figure 3.2 Interpretation of rubella surface glycoproteins. Left: Tomographic section 
on surface of virion. Right: Depiction of a model of E1 (red) and E2 (blue) glycoproteins 
on virion surface (Battisti et al.,2012a).  
 
 
To delineate the positions of glycoproteins E1 and E2 individually on the viral 
surface, the use of Fabs from monoclonal anitbodies against E1 and E2 separately was 
initially proposed to act as position markers for the two glycoproteins on the viral surface. 
Monoclonal antibodies are divided into two regions, the Fc (Fragment crystallizable) (50 
kDa) part and the Fab (Fragment antigen binding) (50 kDa) part. The Fab part corresponds 
to the region on antibodies that bind to their antigens. The extra density contribution from 
the Fab fragments was expected to help with the positioning of the individual glycoproteins. 
However, it was later observed that the length of the glycoprotein spikes is variable on the 
viral surface. This was also observed by Battisti et al, 2012a, where it was reported that the 
length of spikes from the membrane surface can vary between 50 Å to 80 Å. In light of this 









Although, the location of Fabs on the rubella virion surface could not be deduced 
using the cryo-electron tomograms, the tomographic reconstructions were analyzed more 
carefully on the basis of new information obtained from the atomic structures of the rubella 
capsid protein. This has helped to establish a more detailed, low resolution, three-







3.2 Materials and methods 
3.2.1 Virus preparation and purification 
 Rubella virus was propagated and purified in a similar way as outlined by Battisti 
et, al, 2012. Vero cells were grown in Dulbecco’s modified Eagle medium with 5% fetal 
bovine serum (FBS) and 1% L-glutamine at 37 ºC in a 5% CO2 incubator. Passage number 
of the cells was kept below thirty. The cells were infected with the F-therein strain of 
rubella virus when the cells were approximately 85% confluent. Infection with the virus 
was carried out by overlaying the cells with Dulbecco modified Eagle medium (DMEM) 
supplemented with 1 mM L-glutamine and the virus stock for 2 hours at 35 ºC. The 
multiplicity of infection was maintained between 0.1 to 0.5. The medium containing the 
virus was then removed and the cell medium was changed to DMEM supplemented with 
1 mM L-glutamine and 2% FBS. The cells were then incubated for 2 days at 35 °C. 
Deterioration of the cells was observed, with cell death occurring at a rapid rate beyond 48 
hours of cell growth after infection. 
The supernatant from the cell culture was collected and centrifuged for 10 min at 
6000 rpm in a Beckman Coulter centrifuge (rotor ID: JA-10). PEG precipitation was 
carried out by the adding PEG-8000 to a final concentration of 8% and stirring overnight 
at 4 °C. The precipitates from this step were collected by centrifuging for 1 hour at 9500 
rpm (rotor ID: JA-10). The pellets were re-suspended in NTE buffer (20 mM Tris, pH 8.0, 
120 mM NaCl and 1 mM EDTA) and then concentrated to less than 2 ml volume. This 
mixture was layered onto a 0 to 54% Opti-prep-NTE gradient and centrifuged at 32000 
rpm for 2 hours in an ultracentrifuge (rotor ID: SW-41). Illumination of the gradient 
centrifuge tubes after this step showed the presence of purified virus as a single white band. 
The band region was collected and buffer exchanged into NTE buffer using a 100 kDa-
molecular-mass cutoff centrifuge filter (Amicon). 
 
3.2.2 Preparation of Fab fragments 
 Monoclonal antibody against the E1 glycoprotein named 1B9, was kindly provided 
by Dr. Tom Hobman, University of Alberta, Canada. The Fab fragments were generated 






The antibody solution at a concentration of 4 mg/ml was digested using immobilized 
papain protease for 4 hours at room temperature with gentle stirring. The digested sample 
was purified over a protein-A affinity column that binds to the Fc fragment alone, thus, 
purified Fab fragments can be collected in the flow-through from the column. The purified 
Fab fragments were concentrated to a final concentration of 10 mg/ml. 
 
3.2.3 Preparation of samples for cryo-electron tomography 
 Purified rubella virus was mixed with 1B9 Fab in a 1:4 molar ratio and incubated 
for 30 minutes at room temperature. Bovine serum albumin-conjugated 10 nm gold 
particles (Aurion, Wageningen, Netherlands) were added to aliquots of purified rubella 
virus particles and the virus-Fab mixture. 3 µl of these mixtures were applied to holey EM 
grids (R 2/2 Quantifoil; Micro Tools GmbH, Jena, Germany), and frozen in liquid ethane.  
 
3.2.4 Cryo-electron tomography of rubella virions 
The sample grids were imaged under low-dose conditions at 300 kV with an FEI 
Titan Krios microscope equipped with a Gatan Tridiem energy filter (GIF 863). Tilt series 
images were collected over a range of ±66° at 2.0° intervals at a magnification of 19500X. 
The total electron dose for a particular tilt series was kept in the range of 120 electrons/Å2. 
Images were acquired at a defocus of around 7 μm underfocus. Pixels of the tilt series 
images were bin averaged to yield a final pixel size near 1.5 nm. Tilt-series images were 
aligned using the colloidal gold particles as fiducial markers and reconstructed using the 
weighted back-projection method as implemented in the IMOD software package (Kremer 







3.3 Results and Discussion 
Cryo-electron microscopic (Cheng et al., 1995; Mukhopadhyay et al., 2006) and 
tomographic (Battisti et al., 2012b) reconstructions of alphaviruses show that there is a 40 
Å-wide gap at a radius of approximately 190 Å between the lipid membrane and the 
nucleocapsid RNA. The alphavirus capsid protein pentamers and hexamers are situated in 
this gap and produce regions of higher density crossing the gap at intervals of around 80 
Å. A similar gap with thickness ranging from 40 Å to 70 Å, crossed by regions of higher 
density separated by about 90 Å, exists in rubella virus tomograms (Battisti et al., 2012b) 
(Figure 3.3A,B), except that the mean radius of the gap is at approximately 240 Å instead 
of  190 Å. The similarity of these features in alphaviruses and rubella virus suggests that 
the positive surface of the capsid protein rows of dimers is close to the lipid membrane and 
the alternate capsid protein dimers span the gap in tomograms. This observation overrides 
our previous conclusions based on volume calculations to determine the site of the capsid 
protein in the virion (Battisti et al., 2012b). 
In many enveloped viruses, the lipid membrane faces a positively charged protein 
surface. Of particular relevance to rubella virus is the nucleocapsid of Sindbis virus 
(Mukhopadhyay et al., 2006) and Ross River virus (Cheng et al., 1995), alphaviruses 
whose nucleocapsid surface is positively charged and surrounded by lipid membranes. A 
second example is the double-stranded DNA containing Paramecium bursaria Chlorella 
virus-1 whose capsid protein hugs the exterior of the internal lipid membrane 
(Nandhagopal et al., 2002). A third example is the matrix protein of the pleomorphic 
Newcastle disease virus which is closely associated with the interior of the viral lipid 
envelope (Battisti et al., 2012b). Thus, it seems likely that the rubella capsid protein also 
assembles with a predominantly positive surface close to and facing the viral membrane.   
If we assume that the positive surface of the capsid protein rows in P22121and C2221 
crystal forms (Section 2.3.4 and Figure 2.14) is positioned parallel to the rubella virion 
membrane, then the capsid protein dimer axes would be roughly perpendicular to the viral 
membrane. Furthermore, alternate dimer axes are in opposite directions, implying that 
every second dimer makes close contacts with the membrane. These contacts are separated 






Some rubella virus tomograms show short, parallel ridges separated by 
approximately 90 Å below the viral membrane. These ridges likely correspond to the rows 
of capsid protein imers that occur in the crystal structures (Figure 3.3D,E). Although the 
rows of dimers found in the crystals are linear, it is possible that in virions, the rows are 
slightly bent as would be required for the formation of spherical or elongated RV particles. 
Tomograms of rubella virus particles show ridges, separated by about 90 Å, on the viral 
surface formed by the glycoproteins (Battisti et al., 2012a). These ridges are approximately 
orthogonal to the rows of capsid protein dimers (Figure 3.3D,E). Thus the arrangement of 
the glycoproteins E2 and E1 in rubella virions are correlated with the organization of the 













Figure 3.3 Rubella virus tomograms. (A, B) Central section of two rubella virus particle 
tomograms. Magenta arrows: glycoprotein plus membrane layer (average thickness = 100 
Å).Yellow arrows: gap between membrane and internal RNA core. The C-terminal domain 
of the capsid protein is seen as regions of density (dotted arrows) crossing the gap. Cyan 
arrows: region occupied by RNA plus N-terminal domain of the capsid protein. (C) 
Diagram of a RV virion cross-section showing the ectodomains of E1 (blue) and E2 
(magenta) glycoproteins, the capsid protein dimer (yellow) and genomic RNA (red). The 
grey region denotes the membrane layer (dark grey) plus the glycoproteins. In the 
magnified section, shown are the polypeptide connections (thin lines) of the N-termini (□) 
and C-termini (Δ) of the capsid protein to the RNA and membrane, respectively. The filled 
and open shapes denote the termini pointing towards and away from the plane of the paper. 
(D) A section near the surface of a RV virion, at a distance of 345 Å from the particle 
center. (E) A section at a distance of 210 Å from the particle center and below the external 
surface of the virion shown in D. The separation of pixels in the tomogram is 15 Å. The 




















Based on the above structure of the rubella virion, it was hypothesized that the 
oligomerization of capsid protein dimers, as seen in the C2221 crystal form (Section 2.3.4), 
should be essential for virion assembly and infection. Experiments were conducted by 
Steven Willows in Dr.Tom Hobman’s group at the Univeristy of Alberta, Canada, to test 
the above hypothesis. Results and conclusions from those experiments are briefly described 
below. 
 
If the organization of capsid protein into rows of dimers is important for the assembly 
of the rubella virion (Figure 2.14C), disrupting the hydrogen bonding between adjacent 
dimers should have a detrimental effect on virus assembly and/or infectivity. The inter-
dimer molecular interface involves amino acid residues 218-221, Gly-Val-Trp-Gly 
(GVWG). To determine whether the inter-dimer interface of the capsid is important for 
infectivity, the rubella capsid gene was modified to encode two proline substitutions 
(PVWP) that should disrupt the hydrogen bonding interactions. Plasmid-based expression 
of the PVWP capsid protein in transfected cells verified that this mutant was identical in 
apparent molecular weight to wild-type (Wt) capsid protein (Figure 3.4A). The mutant 
protein also exhibited an identical subcellular localization to the Wt capsid protein (Figure 
3.4B). 
Cells were transfected with in vitro synthesized Wt and PVWP genomic RNAs. The 
resulting viral titers were determined at 1-3 days post-transfection. Whereas the specific 
infectivity of Wt RV genomic RNA approached 106 plaque-forming units per microgram, 
cells transfected with PVWP genomic RNA did not produce detectable amounts of 
infectious virus (Figure 3.4C). The production of p150, a viral replicase protein that is 
translated directly from the viral genomic RNA, was assayed to monitor the efficacy of 
RNA transfection. Expression of p150 was similar for the Wt and mutant after 1 day. The 
p150 levels remained relatively constant over time in cells transfected with the mutant RV 
genome. In contrast, in cells transfected with Wt RV RNA, levels of p150 steadily 
increased along with capsid levels in a time-dependent manner, a scenario that is consistent 
with assembly of infectious virus and their infection of neighboring cells (Figure 3.4D). 






because no infectious virus was being made and therefore, mutant capsid is only made in 
the cells that were originally transfected with the "infectious" RNA (Figure 3.4D). To 
determine if the PVWP capsid protein could support assembly and secretion of virus 
particles, Vero cells were transfected with plasmids encoding the Wt or PVWP mutant 
capsid protein plus glycoproteins E2 and E1. It has previously been shown that co-
expression of the rubella virus structural proteins results in the assembly of virus-like 
particles in the Golgi, followed by secretion into the medium (Hobman et al., 1994). The 
virus-like particles, which are antigenically and immunologically indistinguishable from 
infectious virions (Qiu et al., 1994), can easily be recovered from the cell media by 
ultracentrifugation (Garbutt et al., 1999; Law et al., 2001). Using this assay, it was 
observed that virus-like particles were only secreted from cells expressing Wt capsid, E2 
and E1 (Figure 3.4E). Together, these data suggest that the interface between capsid 
dimers, as seen in the orthorhombic crystal forms, is critical for assembly of capsid protein 













Figure 3.4 Interaction between neighboring capsid dimers is essential for infectious 
virus production. (A) Lysates of Vero cells transfected with plasmids encoding wild type 
(Wt) or the PVWP mutant capsid protein were subjected to immunoblotting with anti-RV 
serum. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading 
control. (B) Indirect immunofluorescence was used to detect localization of Wt and the 
mutant capsid protein in transfected cells. (C) Vero cells were transfected with in vitro 
synthesized infectious RNA encoding Wt or PVWP mutant RV genome. Viral titers were 
determined 1-3 days post-transfection and the specific infectivities (plaque-forming 
units/µg DNA) of the infectious clones were calculated. (D) Immunoblot analyses of cells 
transfected with viral RNAs showing expression of capsid and the viral replicase protein 
p150.  Actin was used as a loading control. (E) Vero cells were transfected with plasmids 
encoding Wt or PVWP capsid and glycoproteins E2 and E1 or vector alone (V). Forty-
eight hours post-transfection, virus-like particles were recovered from media by 








CHAPTER 4. IN VITRO ASSEMBLY OF RUBELLA NUCLEOCAPSID CORES 
4.1 Introduction 
 Rubella virus assembly and budding occurs on the Golgi membrane. This is 
different from the budding process of the related alphaviruses in which virus budding 
occurs from the plasma membrane. The alphavirus nucleocapsids are assembled in the 
cytoplasm whereas the rubella virus nucleocapsid assembly occurs on the Golgi membrane 
in synchronization with virus budding (Hobman and Chantler, 2007). 
  Even though, in vivo the rubella capsid protein is found in association with the 
membranes during virus assembly (Frey, 1994), there is no study reporting the requirement 
of membrane attachment for nucleocapsid assembly. Studies reporting production of 
rubella VLPs (virus-like particles) using cDNA encoding only the structural proteins of 
RV have shown that the viral genomic RNA is not required for particle assembly (Hobman 
et al., 1994). The amino acid region 28 to 56 on the capsid protein has been reported to 
specifically bind to the rubella viral RNA, while a few other regions on the capsid protein 
have been shown to bind non-specifically to nucleic acids (Liu et al., 1996).   
In vitro assembly systems for Sindbis virus (type member of alphavirus genus) 
nucleocapsid using recombinantly produced capsid protein have been established 
(Tellinghuisen et al., 2000). The aim of the work reported in this chapter is to establish 
conditions to form rubella nucleocapsid assemblies in vitro. These nucleocapsids would 
then be used for electron microscopy studies to gain further information on the structure of 







4.2 Materials and Methods 
4.2.1 Cloning 
 Different lengths of the rubella capsid protein were cloned into pET28a (Novagen) 
and pET44a (Novagen) vectors. The pET28a vector constructs contain an N-terminal His 
tag. The pET44a vector constructs contain a His tag plus NusA tag at the N-terminus of 
the protein of interest. NusA is a transcription termination/antitermination protein from 
E.coli which has high solubility when expressed in the bacterial system. Preparation of the 
plasmid constructs was carried out similarly as described in section 2.2.1. A list of the 
constructs along with their primer sequences are given in Table 4.1. 
 
Table 4.1 List of rubella capsid protein constructs 
Rubella capsid 
protein residues 
Fusion Tag Primer sequence (5’-3’)** 
(F- forward, R- reverse) 
RVC-N9-2771 N-terminus 6X His (F)TAACATATGATGGAGGACCTCCAGA
AG 
(R)TTAAAGCTTTCAGCGGATGCGCCA 





RVC-N30-2771 N-terminus 6X His (F)TAACATATGGGCGCCTCGCAGTCG 
(R)TTAAAGCTTTCAGCGGATGCGCCA 













Table 4.1 Continued 





RVC-N65-2771 N-terminus 6X His (F)TAACATATGAACCGGGGCCGT 
(R)TTAAAGCTTTCAGCGGATGCGCCA 
RVC-N87-2771 N-terminus 6X His (F)TAACATATGACTCGCTCCCAGACT 
(R)TTAAAGCTTTCAGCGGATGCGCCA 
RVC-N109-2771 N-terminus 6X His (F)TAACATATGATGCAAACCGGGCG 
(R)TTAAAGCTTTCAGCGGATGCGCCA 
1RVC denotes rubella capsid protein and N refers to the amino terminus of the protein 
followed by the amino acids residue numbers 
 
 
4.2.2 Expression of plasmid constructs 
 Expression tests were carried out with the positive plasmid clones similar to the 
procedure described in Section 2.2.2. 
 
4.2.3 Large-scale expression and purification of pET44a constructs 
 The pET-44a capsid protein constructs RVC-N9-277, RVC-N30-277 and RVC-
N44-277, that showed soluble expression of the fusion protein, were used for larger scale 
expression of the protein. The clones were grown in 1 liter LB medium at 37 °C to an O.D 
reading of 0.6-0.8. The expression of the fusion protein was then induced with 1 mM IPTG. 
The induced cultures were grown at 25 °C for 6 hours before harvesting the cells. The cells 
were pelleted by centrifugation (Rotor ID: JLA-9.1) at 6000 rpm for 15 minutes at 4 °C. 
The cell pellets were re-suspended in 50 mM Tris, 500 mM NaCl, 20 mM imidazole (buffer 
A) and lysed in ice using a sonicator. The lysed cells were clarified by centrifugation at 
15,000 rpm for 25 minutes using a Beckman Coulter centrifuge (Rotor ID: JA-20). The 
supernatants were incubated with Ni-NTA beads (Qiagen) under constant stirring for 1 






column. The column was washed with 10 column volumes of buffer A followed by 2 
column volumes of cleavage buffer (20 mM Tris at pH 8.0, 120 mM NaCl, 10 mM CaCl2). 
The beads with the fusion protein were then incubated with 0.02 µg/ml of enterokinase 
(New England Biolabs) for different time intervals (2, 5 and 16 hours) at room temperature 
to test the efficiency of protease cleavage. The protease cleavage products were then 
collected and analyzed using 12% SDS-PAGE. 
 
4.2.4 Large-scale expression and purification of pET28a constructs 
 The soluble pET28a constructs, RVC-N65-277 and RVC-N85-277, were scaled up 
for larger volume expression and purification. The procedure for protein expression and 
purification was similar to the procedure outlined in the previous section. However, the 
expressed proteins that were bound to the Ni-NTA column were not treated with 
enterokinase. The bound proteins were eluted from the column using 5 column volumes of 
buffer containing 50 mM Tris, 500 mM imidazole and 500 mM NaCl at pH 8.0. The eluted 
proteins were applied to a Superdex 200 gel filtration column (GE Lifesciences) and 
analyzed using negative-stain cryo-electron microscopy. 
 
4.2.5 Negative-stain cryo-electron microscopy 
 About 3µl of the sample was added to home-made holey carbon grids (EMS, G400-
Cu) and incubated for 1 minute. 3 µl of 1% uranyl acetate solution was added to this and 
incubated for 30 seconds. The grid was washed thrice with 15 µl of distilled water and 
blotted with Whatmann filter paper. The grids were then imaged at 200 kV in the FEI 
CM200 microscope at a magnification of 35,000X and 17,000X with defocus between 5-7 
µm underfocus.     
 
4.2.6 Purification of RVC-N65-277-His protein dimers 
 The RVC-N65-277 construct in pET28a was expressed as outlined in Section 4.2.4. 
Twenty units of benzonase (Sigma) was added along with 5 mM MgCl2 (final concentration) 
and protease-inhibitor cocktail mini-tablet (Roche) to the cell pellets during re-suspension 






Section 4.2.4. The only difference was that after cell lysis, the lysate was incubated under 
constant stirring at room temperature for 1 hour before clarifying the lysate by 
centrifugation. The purified protein sample was analyzed using Superdex 200 (GE 
Lifesciences) size-exclusion column. The buffer condition for the size-exclusion 
experiment was 50 mM Tris at pH 8.0 with 500 mM NaCl. 
 
4.2.7 Analysis of capsid cores 
Size-exclusion chromatography 
 The capsid oligomers were applied to Hi-prep Sephacryl S-400 column (GE 




 The capsid oligomers were run on a 1% agarose gel in TAE buffer (40 mM Tris, 
20 mM acetic acid, 1 mM EDTA at pH 8.0) at 90 volts for 2 hours at room temperature. 
The gel was then imaged for presence of nucleic acids using UV transillumination and then 
subsequently stained with Coomassie blue to detect presence of protein. 
 
Cryo-electron electron microscopy  
The RVC-N65-277-His protein complex was frozen as a vitrified sample in liquid 
ethane on 200 mesh EM grids (R 2/2 Quantifoil; Micro Tools GmbH, Jena, Germany). The 
grids were imaged at 200 kV under the FEI CM200 microscope at a magnification of 
38000X (effective magnification 51500X) and defocus of 5 μm underfocus. The grids were 
also imaged at 300 kV with an FEI Titan Krios microscope equipped with a Gatan Tridiem 
energy filter (GIF 863). CCD (charge-coupled detector) data was collected at a 
magnification of 47000X (effective magnification 79100X) at defocus of about 3.5 μm 
underfocus. The collected images were boxed using the EMAN software package (Ludtke 







4.3.1 Cloning and expression 
 The positive clones for the different constructs of the rubella capsid protein were 
tested for soluble expression at 25 ºC for 6 hours on induction with 1mM IPTG. The results 
for the protein expression tests are given in Table 4.2. 
 
Table 4.2 Expression tests on the rubella capsid protein constructs. 
 N-terminal His Tag N-terminal (His + NusA) Tag 
RVC-N9-2771 Insoluble Soluble 
RVC-N30-2771 Insoluble Soluble 
RVC-N44-2771 Insoluble Soluble 
RVC-N65-2771 Soluble N/A 
RVC-N87-2771 Soluble N/A 
RVC-N109-2771 Insoluble N/A 
1RVC denotes rubella capsid protein and N refers to the amino terminus of the protein 
followed by the amino acids residue numbers 
 
 
4.3.2 Large-scale expression and purification of pET44a constructs 
The pET44a constructs of the rubella capsid protein were all soluble on expression. 
But protease treatment (using enterokinase) to remove the fusion tag always resulted in 
non-specific cleavage of the proteins in all constructs. Different buffer conditions, 
incubation temperatures and length of incubation were tried but were unsuccessful. The 
most obvious protein bands after enterokinase treatment for the fusion protein RVC-N9-
277 with NusA tag was sent for mass-spectrometry analysis (Electrospray ionization, LC-
MS/MS) at the proteomics facility, Bindley Biosciences, Purdue University. The mass-
spectrometry results indicated that band#3 is the rubella capsid protein (Figure 4.1). The 
size of the rubella capsid band on the gel was much lower than the actual construct, but 






results showed that the amino terminal region of the rubella capsid protein was disordered 




Figure 4.1 12% SDS-PAGE. Lane 1: Standard marker, Lane 2: Fusion protein (RVC-N9-
277-NusA), Lane 3: Protein products after enterokinase treatment (0.5% (v/v) enzyme after 




4.3.3 Large-scale expression and purification of the pET28a constructs 
Soluble expressions of the pET28a constructs were obtained for capsid protein 
regions 65-277 and 87-277 amino acids. These constructs were purified with Ni-NTA 
affinity column using a linear gradient for elution (Figure 4.2), followed by gel filtration 
chromatography. Gel-filtration chromatography showed that the purified proteins were 








Figure 4.2 12% SDS-PAGE of Ni-NTA purified proteins. A. Purified RV-N65-277-His 
protein. Lane 1: Protein Ladder. Lane 2: clarified lysate. Lane 3: flowthrough from the Ni-
NTA column. Lane 4: wash from the column. Lane 5-13 are the elution fractions. B. Lane 
1: Protein Ladder marker, Lane 2: clarified lysate, Lane 3: flowthrough from the Ni-NTA 
column, Lane 4: wash from the column, Lanes 5-13: elution fractions. B. Purified RV-
N87-277-His protein. Lane 1: Protein ladder, Lane 2: clarified lysate, Lane 3: flowthrough 
from the Ni-NTA column, Lanes 4 and 5: wash from the column, Lanes 6-15 are the elution 










Figure 4.3 Gel filtration absorption curves at 280nm. The y-axis is in mAu (milli 
absorption units) and the x-axis is the elution volume (ml). A. Absorption curve for RVC-
N65-277-His on superdex-200 column. B. Absorption curve for RVC-N87-277-His on 
superdex-75 column. The black arrow indicates the elution position of the protein of 
interest in each. Both proteins elute in the void volume. 
 
 
 As the capsid protein is expected to form large assemblies, these protein aggregates 








(Figure 4.4). The images showed some spherical shaped particles that might resemble 
capsid cores. Based on these initial experiments, further work was mainly carried out with 




    
     
Figure 4.4 Negative stain images of capsid cores. A and B. Negative stain images of 
RVC-N65-277-His aggregates (Magnification 35000X). C and D. Negative stain images 
of RVC-N87-277-His aggregates (Magnification 17000X). Black arrowheads point at 








4.3.4 Purification of RVC-N65-277-His capsid protein dimer 
 RVC-N65-277-His protein can be purified in its dimeric form by treating the 
bacterial cells with benzonase in the presence of 5 mM MgCl2 during cell lysis. The cell 
lysate was then incubated at room temperature for 1 hour before centrifugation to remove 
cell debris. The RVC-N65-277-His protein was purified using Ni-NTA column. The dimer 
form could be separated from the larger complexes using a size-exclusion column (Figure 
4.5). The dimeric RVC-N65-277-His was stable only at salt (NaCl) concentrations of 500 
mM or above. Lowering of salt concentration resulted in precipitation of the protein. The 
yield of dimeric RV-N65-277-His with respect to the oligomeric form could be increased 




Figure 4.5 Elution profile at UV wavelength of 280nm from superdex-200 column. 
Peak 1 is the RVC-N65-277-His nucleocapsid complex and peak 2 is the dimeric form of 











4.3.5 Analysis of capsid cores 
Size-exclusion chromatography 
 The RVC 65-277 protein-nucleic acid complex was run on a Sephacryl S-400 
column which is used for separating particles with very large molecular weights (in the 
kilo and mega Dalton ranges). The elution profile from this column (Figure 4.6), when 
compared with the standard elution curves for this column, indicated that the RVC-N65-





Figure 4.6 Gel filtration absorption curve for RVC-N65-277 at wavelength of 280nm. 
The y-axis is in mAu (milli absorption units) and the x-axis is the elution volume (ml). The 
black arrow indicates the elution position of the protein of interest. The dotted line 
indicated the position of sample injection. 
 
 
Agarose gel assay 
 The purified RVC 65-277 aggregate complexes were analyzed using agarose gel. 






subsequently stained with Coomassie blue to detect presence of protein. The results are 
shown in Figure 4.7. The RVC-N65-277-His complexes did not move much into the gel, 
but the position of the nucleic acid band overlapped well with the position of the protein 
band, indicating that the complexes were between protein and nucleic acids. These 
complexes were not homogenous as could be seen from the smearing of the bands. As the 
complexes were formed during lysis and purification of the recombinant protein, these 
nucleic acid fragments must be random DNA/RNA from the bacterial cell. Presence of 
nucleic acids in the nucleocapsid complexes could also be detected using an UV 




    
Figure 4.7 Agarose gel assay. Left: UV transillumination of agarose gel. The bright bands 
indicate nucleic acids. Lane 1: RVC-N65-277-His, Lane 3: Standard ladder with highest 
band size of 2 kb. Right: Lane 1 of agarose gel after staining with Coomassie blue. Dark 
bands indicate protein content. The black arrows indicate the position of bands on both the 
gel. 







  The capsid core complexes were next prepared for analysis using cryo-electron 
microscopy. Freezing of the grids had some issues with forming good ice. This was because 
the protein complexes were not uniform as seen from negative stain images. The presence 
of some very large aggregates caused very thick ice formation on freezing. After testing 
different blotting times during freezing, grids were frozen with workable ice thickness. 
These grids were analyzed under the CM200 transmission electron microscope. The 
contrast of sample on the grid was very low, hence high defocus was needed to identify 
regularly shaped particles. Some of these particles are shown in Figure 4.8. These particles 
have varied sizes and appear hollow. Regularly shaped particles made up approximately 




Figure 4.8 Boxed particles of RVC-N65-277 cores. Particles from CCD images collected 
at 38000X magnification on the CM200 microscope. Black is high density. Scale bar 








 Frozen grids of the nucleocapsid particles were then analyzed under the Titan-Krios 
microscope and CCD data was collected. Using the Titan microscope, particles with 
different shapes and sizes were identified. About 100 CCD images were collected with 2-
3 particles per image. These were then boxed using the EMAN software package and 
analyzed for similarities between particles. Some of the boxed particles are shown in 
Figure 4.9. The rubella nucleocapsid cores appeared to have a smooth surface. The 
diameter of the particles ranged from 200-900 Å. The core particles also showed two 
concentric layers of high density. The inner part of the core appeared to be less dense than 




Figure 4.9 Boxed particles of RVC-N65-277 cores. Particles from CCD images collected 








Nucleocapsid core formation has been well studied for alphaviruses. For the rubella 
virus, there are no previous reports of in vitro assembly of nucleocapsid cores. From the 
above study, it is clear that though the formation of rubella virus nucleocapsid cores occurs 
on the Golgi membrane in infected cells, presence of a membrane is not required for 
formation of the nucleocapsids. In alphaviruses, capsid protein constructs with truncations 
of up to 81 amino-terminal residues can still interact with nucleic acids, but core formation 
occurs spontaneously only with constructs having truncations up to 19 amino-terminal 
residues (Tellinghuisen et al., 2000). In contrast, with rubella virus, capsid constructs with 
truncations up to 87 amino-terminal residues have the ability to form nucleocapsid cores. 
Moreover, the recombinantly produced rubella capsid protein constructs seem to 
spontaneously form nucleocapsid cores during cell growth and lysis. This is different from 
the alphavirus capsid protein, which can be purified in its protomeric form from cells 
without using RNase/DNAse treatment. However, in rubella virus and alphaviruses, capsid 
cores can be formed in the presence of non-specific nucleic acids just as in alphaviruses. 
The rubella nucleocapsid cores have different shapes and sizes as seen from electron 
microscopic images. This again stresses the inherent pleomorphic nature of the virus. The 
EM images show particles with less density in the interior of the particles, which suggests 
that the interior of the nucleocapsids are nearly empty with probably small amounts of 
nucleic acids within it.  
Imaging of the nucleocapsid particles with the Titan microscope show that the cores 
have a smooth outer surface and a double layer architecture. Better quality and detail in the 
images collected from the Titan microscope can be attributed to the fact it has a 4K CCD 
detector as compared to a 1K CCD detector in the CM200. The Titan also has better beam 
coherence, stage stability and higher voltage when compared to the CM200 microscope. 
These properties further contribute to obtaining higher resolution images from the Titan 
microscope.  
Alphaviruses have a single capsid protein layer in their nucleocapsids. For rubella virus, 
there is no direct structural information available on its nucleocapsid features. Thus, the 






interesting and new observation. This suggests that the rubella nucleocapsid cores may 








CHAPTER 5. PURIFICATION OF AN IMMATURE FORM OF RUBELLA 
VIRUS 
5.1 Introduction 
 Freeze-substitution cryo-electron microscopy studies of cells infected with rubella 
virus (Risco.et al., 2003) have identified virion particles that are morphologically different 
from the mature rubella virions. The particles have been named 'immature' particles. These 
immature particles have been found close to budding sites inside infected cells and appear 
as dense, homogenous precursors to the mature rubella virus particles. Only the mature 
form of the  particles are released from the cells. This maturation process takes place in the 
trans-Golgi network. There are, however, no reports on factors that may be responsible for 
maturation of rubella virions. As the Golgi network is at a different pH compared to the 
cytoplasm, it is possible that the change in pH has an effect in maturation of the precursor 
RV virions. In flaviviruses, the acidic pH in the Golgi network is required for processing 
the prM protein on the immature virus to pr peptide and M protein which leads to 
maturation of the virion (Yu et al., 2008). Thus, a potential way to isolate the immature 
RV particles maybe to disrupt the change in pH in the Golgi network and analyze its effect 






5.2 Materials and Methods 
5.2.1 Virus preparation and purification from cell medium 
Ammonium chloride was used to neutralize the pH gradient in the secretory 
pathway of cells. It has been used successfully to purify immature dengue virus, maturation 
which requires low pH induced cleavage of its pr peptide (Yu et al., 2008). Thus, the rubella 
virus particles were propagated and purified in a similar way as described in Section 3.2.1 
with a modification to include 20mM ammonium chloride (final concentration) to the cell-
growth medium after virus infection.  
 
5.2.2 Purification of intra-cellular virions 
 Protocol for purification of the intracellular virions was adapted from Aboud et al., 
1982. Vero cells infected with rubella virus and grown in cell medium containing 20mM 
ammonium chloride for 48 hours, were washed 2-3 times with cold PBS (phosphate buffer 
saline, pH 7.4). The cells were then treated with 1% trypsin for 2-3 minutes at room 
temperature to disperse the cells. Medium containing DMEM supplemented with 5% FBS 
was added to the cells and the mixture was pelleted at 1000 x g for 10 minutes. The cell 
pellets were washed with cold PBS 2-3 times. The cell pellets were then re-suspended in a 
hypotonic buffer containing 20 mM Tris, 10 mM NaCl and 15 mM MgCl2 at pH 8.0 for 15 
minutes at 4 ºC. The suspension was homogenized using 20 strokes in a Dounce glass 
homogenizer with a tight-fitting pestle (7 ml volume). The homogenate was then vortexed 
for 5 minutes. The vortexed mixture was centrifuged for 15 minutes at 4000 rpm to remove 
cell debris. The supernatant was again centrifuged at 15000 rpm (rotor ID: JA-20) for 20 
minutes to remove organelles and broken cell debris. Sodium chloride was then added to 
the supernatant to bring the salt concentrations to 120 mM in the sample. This was mixed 
with 8% of PEG-8000 (final concentration) for precipitation of the virus particles. Further 










5.2.3 Cryo-electron microscopy 
 The virus samples were frozen with BSA-conjugated 10 nm colloidal gold solution 
as outlined in Section 3.2.3. The grids were imaged using CCDs in the FEI Titan-Krios 







Rubella infected cells treated with ammonium chloride (NH4Cl) exhibited 
degradation of cellular structure and cell death similar to untreated rubella infected cells. 
However, the yield of purified virus from the NH4Cl treated rubella-infected cell medium 
was nearly ten times lower than the un-treated rubella preparations. Very few particles 
could be observed with cryo- EM (Figure 5.1). Thus, the addition of NH4Cl had a 
detrimental effect on virus yields during purification.  
It was hypothesized that this reduction in virus yield may be due to the inability of 
the ‘immature’ rubella virus particles to bud out of the cell. Thus, the infected Vero cells 
(treated with ammonium chloride) were lysed and analyzed for the presence of intracellular 
virus particles. Preparations from the Vero cell lysates were applied to an Opti-prep 
gradient. Analysis of the gradient column after ultra-cetrifugation did not show the 




Figure 5.1 Cryo-electron microscopic images of immature rubella particles. The black 
arrowheads denote the virus particles. The other black dots are the 10 nm BSA-gold 











Occurrence of maturation in the rubella virus life-cycle has been reported for the 
first time by Risco et al., 2003. The maturation process has only been described 
phenotypically, and factors affecting the process are unknown. In this chapter, the effect of 
destroying the pH gradient in infected cells was tested as a possible factor for the 
maturation of rubella virions. The experimental observations show that the addition of 
ammonium chloride to disrupt the pH change in infected cells had a detrimental effect on 
the rubella virion production. As the assembly of virions occurs on the Golgi membranes 
and budding of the virus takes place into the Golgi, it is probable that disrupting the pH of 
the infected cells has an adverse effect on virus assembly and, in turn, inhibits virus 
production. The lower pH of the Golgi, thus, may be required for triggering the virion 
assembly process and not for the maturation process. The maturation of the rubella virions 
could be due to other factors, such as, some form of proteolytic processing of the virion 
components in the Golgi leading to re-arrangement of the components in the virion. 
However, further studies would be required to test this hypothesis. At this stage, it is not 
yet clear as to what other factors might be involved in triggering the maturation of the 
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ANALYSIS OF DRUG CANDIDATES AGAINST DENGUE VIRUS 
1. Introduction 
Flavivirus is a genus under the family Flavivirideae which also includes the genera 
pestivirus and hepacivirus. There are nearly 70 different species of flaviviruses, many of 
which cause human diseases. Some of the well-known flaviviruses are the dengue virus, 
West-Nile virus, yellow fever virus, Japanese-encephalitis virus and tick-borne 
encephalitis virus (Lindenbach et al., 2006). 
Dengue virus is a mosquito-borne flavivirus. It is an icosahedral, enveloped virus 
containing an un-segmented, positive-sense, single stranded RNA genome. The mature 
virus particle has a diameter of about 500 Å (Kuhn et al., 2002). The virus is transmitted 
by the Aedes aegypti mosquito. Dengue fever, which is caused by infection of any of its 
four serotypes, is characterized by high fever, severe headache and body pain. Infection of 
an individual with more than one serotype of dengue virus causes dengue hemorrhagic 
fever, which can be fatal if unrecognized (Lindenbach et al., 2006). A possible reason for 
the increased severity during a secondary infection of dengue virus is antibody dependent 
enhancement (ADE) of the virus infection. ADE can be described as an enhancement in 
virus infection in the presence of sub-neutralizing concentrations of the virus antibodies. 
The presence of significant variations between the different dengue virus strains can result 
in a scenario where the antibody against the first infection is not suitable to neutralize a 
secondary infection. However, partial cross-reactivity of the virus strain causing the 
secondary infection with the antibody to the first infection can result in ADE (Halstead and 
O’Rourke, 1977). There are about 100 million cases of dengue infection reported 






Dengue virus, including other flaviviruses, has a genome size of 10.7 kb and 
encodes three structural proteins and seven non-structural proteins. The three structural 
proteins are the capsid protein, the E glycoprotein and the prM protein. The seven non-
structural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 are involved with 
viral replication. The capsid protein interacts with the viral RNA and forms the inner core 
of the virus. The capsid plus RNA core is surrounded by a lipid envelope. The prM and E 
glycoproteins are arranged on the outer surface of the virion. The prM protein has three 
domains: pr, M and a carboxy terminal transmembrane region. The E glycoprotein is the 
major glycoprotein that is involved in receptor attachment and fusion of the virion with the 
infected cell (Lindenbach et al., 2006; Perera and Kuhn, 2008). 
Dengue virus exists predominantly in an immature and mature form. The immature 
form exists in nature only inside the host cell. It has 180 copies of the prM and E 
heterodimer on its surface forming a spiky exterior to the viral particle (Zhang et al., 2003) 
(Figure A 1A). The dengue virus particles assemble and bud into the endoplasmic 
reticulum as immature particles. These subsequently travel via a secretory pathway to the 
Golgi apparatus, during which, they are exposed to low pH. This acidic environment causes 
a conformational change in the E protein which disassociates it from the prM protein and 
induces it to form E homodimers. These homodimers lie flat against the viral surface giving 
the maturing virion a smooth appearance. During maturation, the pr peptide is cleaved from 
the M peptide by the host protease, furin. The pr peptide stays associated with the E protein 
until the mature virus particle is released into the extracellular environment (Yu et al., 
2008). The glycoprotein shell of the mature virion consists of 180 copies each of the E 







Figure A 1 Dengue virus structures. A. Immature dengue virion. The spike structure on 
the virion surface is indicated by a circle. B. Mature dengue virion. Figure reproduced from 
Mackenzie et al., 2004. 
 
 
There are currently no vaccines or anti-viral therapies available for dengue that can 
provide immunity against all the four serotypes. Thus, considerable effort is being focused 
on arriving at a solution to combat the virus infection and spread. For antiviral drug 
development against dengue virus, one of the highly targeted regions on the virus structure 
is the region between domain I and II of the E protein on the virus envelope. 
The E protein is a 495 amino acid long glycoprotein. It consists of a transmembrane 
region, a stem region and an ectodomain region. The ectodomain region consists of three 
domains. Domain I is the central domain and consists of an eight-stranded beta barrel. 
Domain II is linked to domain I by four peptide chains. This is the dimerization domain 
with a fusion loop at its distal end. Domain III is also connected to domain I by a peptide. 
Domain III is an immunoglobulin-like domain that harbors the receptor binding region 
(Modis et al., 2003; Rey et al., 1995). The hinge region between domain I and II has been 
observed to have different angles during the life cycle of the virus. These movements and 






to the cell. Thus, the hinge region between domains I and II is a popular site for drug 
targeting, as effectively hindering the motion between these two domains can have a 
detrimental effect on virus fusion and virus maturation (Rey, 2003) (Figure A 2A).  
 The project discussed in this chapter was initiated in collaboration with the National 
Institute of Tropical Diseases (NITD), Novartis Co, Singapore, to study the effects of drug 
candidates on dengue virus. The NITD had developed drug candidates that had shown 
efficacy in inhibiting the dengue virus entry into host cells and propagation in tissue culture 
(Wang et al., 2009). The drug candidates were designed to target the hinge region between 
domain I and II of the E protein. Three of these compounds were selected by the team at 
NITD, based on plaque reduction capabilities in cell based assays. The three compounds 
had similar structures and were named NITD-276, NITD-029 and NITD-249. NITD-276 
was the first compound to be sent to the Rossmann and Kuhn laboratories to verify its 
binding position to dengue E protein. It is an organic molecule with a molecular weight of 
about 500Da (Figure A 2B). The other two compounds were sent subsequently for similar 
studies. All three compounds were stored as a 10mM solution in DMSO (Dimethyl 









           
 
Figure A 2 Anti-viral drug candidate against Dengue E protein. A. Structure of Dengue 
E protein dimer. The domains I, II and III are shown in red, yellow and blue respectively. 
Figure modified from Modis et al., 2004. The black arrows indicate the target position of 









2. Material and Methods 
2.1 Recombinant expression of dengue E protein 
 The soluble ectodomain of dengue E protein (sE) was produced recombinantly in 
the Drosophilla melanogaster derived S2 cell line using a protocol established by Long Li, 
a previous graduate student and post-doctoral associate in the Rossmann laboratory. The 
S2 cells are semi-adherent cells that can be either grown as adherent cultures or as 
suspension cultures. Frozen S2 cells transiently expressing dengue sE (to be referred to as 
S2-sE cells further on) were obtained from Long Li. The frozen S2-sE cells were thawed 
and starter cultures were established in a T-25 flask containing 5 ml of Schneider’s 
Drosophila medium supplemented with 10% fetal bovine serum (FBS) and 300 µg/ml 
hygromycin-B (Invitrogen). The cells were grown at room temperatures between 22-27 ºC 
without supplemental carbon dioxide. Once the cells were revived, they were adapted to 
the Ex-cell 420 medium (Sigma) supplemented with 300 µg/ml hygromycin-B. The cells 
were sequentially scaled up to 120 ml in four T-150 flasks. Care was taken to maintain the 
cell density between 2-10×106 cells/ml during each passage. After the cells had been grown 
in the T-150 flasks for 4 days, they were spun down and transferred to two spinner flasks 
with 250 ml, each, of Ex-cell 420 medium without hygromycin. The spinner flasks were 
stirred at approximately 130 rpm. After 5-6 days, the medium volume was scaled up to 2 
litres with initial cell concentration maintained between 2-4×106 cells/ml. The suspension 
cell culture was split into larger spinner flasks and stirred at about 300 rpm under room 
temperature. The cultures were induced for protein expression with 500 µM Copper sulfate 
once the cell concentrations had reached 6-10×106 cells/ml. The medium was harvested 
after 3-5 days post-induction by centrifuging at 9000 rpm for 25 minutes. The supernatant 
was filtered using a 0.45 µm cut-off membrane. 
 
2.2 Purification of dengue E protein 
 Dengue sE (soluble E ectodomain) was purified from the cell culture supernatant 
using an immuno-affinity column. The immuno-affinity column utilized a monoclonal 






 The monoclonal antibody, 4G2, was expressed using hybridoma cells (Henchal et 
al, 1982). The cells were initially grown in a 6 well plate with DMEM plus 20% FBS. Once 
the cells were 80% confluent, they were seeded into 40% BD cell MAb medium (BD 
Biosciences) plus 40% DMEM and 20% FBS. The initial cell density was maintained 
around 3×105 cells/ml. The cultures were gradually adapted to grow in BD medium with 
20% FBS. The cells were re-suspended in 15 ml BD medium plus 20% FBS to attain a 
concentration of 1.5-2×106 cells and transferred to the cell compartment of a CELLine flask 
(INTEGRA Biosciences). The medium compartment of the flask was filled with 1 litre BD 
medium. After seven days, the supernatant was collected for antibody purification. If more 
production of antibody was required, the cultures from the cell compartment in the 
CELLine flask was collected, spun down and added again to the cell compartment at a 
concentration of only 5×106 cells/ml. The medium compartment was topped with 1 litre of 
BD medium. This process could be repeated at least 2-3 more times without significant 
drop in antibody expression. 
 The antibody containing supernatant medium was filtered using a 0.45 µm cut-off 
membrane filter (Amicon). The medium was then loaded on a 1 ml Protein-A column (GE 
Lifesciences). The column was washed with PBS at pH 7.4. The bound antibody was eluted 
using 100 mM glycine at pH 2.7. The elutions were neutralized immediately using 1M Tris 
at pH 9.0 (100 µl of 1M Tris, pH 9.0 for 900 µl of elution volume). 
 The purified 4G2 antibody was then coupled to a 5 ml NHS-activated sepharose 
column (GE Lifesciences) using the manufacturer’s protocol. Briefly, the column was 
washed with 1 ml ice-cold hydrochloric acid and immediately injected with 5 ml antibody 
solution of concentration about 10 mg/ml. The column was sealed and incubated at room 
temperature for 20 minutes. The column was then washed with 100 mM Tris at pH 8.0, 
followed by 100 mM sodium acetate plus 500 mM NaCl at pH 4.0. The prepared column 
was stored in PBS plus 0.05% sodium azide. 
 Dengue sE protein was purified by applying the sample to the 4G2-bound NHS 
column. The column was washed with 10 column volumes of PBS at pH 7.4. The sE protein 
was eluted using 100 mM glycine at pH 2.7 which was immediately neutralized using 1 M 






(GE lifesciencs) with a sodium chloride gradient from 0 to 1 M. The protein was then 
purified using the Superdex 200 gel filtration column (GE) under buffer conditions of 50 
mM Tris and 100 mM NaCl at pH 8.0. The protein was concentrated to a final concentration 
of 3 mg/ml. 
  
2.3 Co-crystallization of dengue E with NITD-276 
The dengue sE protein was crystallized in 100 mM HEPES, pH 7.5, 100 mM 
ammonium sulfate and 30% PEG-3350 in the presence of 1 mM NITD-276 in the 
crystallization drop.   
 
2.4 Data collection and structure determination 
Crystals of the dengue sE protein with NITD-276 were tested at the Advanced 
Photon Source, GM/CA, beamline 23 ID-D and ID-B, Chicago, USA. The datasets were 
indexed using HKL2000. The structure was determined using the molecular replacement 
(MR) method with the program PHASER in the CCP4 software package. The dengue sE 
structure was used as a search model (Modis et al., 2003). 
 
2.5 Cryo-electron microscopy: 
 Sample grids of dengue virus incubated with NITD-276 at room temperature for 30 
minutes had been made by Heather Holdaway, a previous electron microscopist in the 
biological sciences department. Imaging data from the grids were collected by Ye Xiang, 
a former post-doctoral associate in the Rossmann laboratory. The micrographs were 
collected at a magnification of 50,000 X in the 200 kV CM200 microscope using 
underfocus values between 0.8-2.0 µm. The data was processed, from this point on, by 
myself. 
 The micrographs were digitized using a Nikon Scanner. The pixel size of the 
images were 1.244 Å/pixel. About 300 particles were boxed from the images. The particles 
were boxed with a box size twice the diameter of the dengue virus particles (about 1000 
Å). CTF (Contrast Transfer function) correction was applied to each image. The orientation 






model. The aligned 2D images were then reconstructed into a 3D volume. This volume 
was then used as a starting model for the next orientation search. The procedure was 
repeated till the reconstruction converged and did not change anymore. The 3D 
reconstruction procedure was carried out using the EMAN software package (Ludtke et 
al., 1999). 
  
2.6 Iso-thermal calorimetry (ITC) studies using NITD-249 
 ITC is a technique used to measure interactions between ligands, such as proteins 
and peptides, or proteins and other compounds. It is based on the fine changes of heat 
absorption or release that accompanies a binding reaction between two molecules. The heat 
gain or loss is measured as a change in temperature between a reference and sample cell. 
The ligand is injected into the cell containing the protein in pulses (at specific time intervals) 
and the data is collected as a series of spikes of heat flow. The ITC measurements with 
dengue sE and NITD-249 was carried out at the proteomics facility in Birck 
Nanotechnology Centre at Purdue University by Dr. Lake Paul. In this experiment, soluble 
dengue E protein was placed in the sample cell and the drug NITD-249 was injected as the 
ligand.  
 
2.7 Purification of immature dengue virus 
 The propagation and purification of immature dengue virus (strain 16881) was 
conducted in a similar way as outlined by Kuhn et al., 2002. C636 mosquito cells were 
grown in Minimum Essential Medium (MEM) supplemented with 10% FBS, 1% non-
essential amino acids (NEAA) and 1% L-glutamine at 30 ºC in a 5% CO2 incubator. 25-50 
mM HEPES buffer was added to the medium if the cells appeared unhealthy or when the 
medium pH was observed to change. Passage number of the cells before infection was 
maintained well below thirty. The cells were infected with the dengue virus strain when 
the cells were close to 60-70% confluent. Infection was carried out with overlaying the 
cells with MEM containing 1% L-glutamine, 1% NEAA and the virus stock for 2 hours at 
30 ºC. The medium containing the virus was then removed and the cells were overlaid with 






medium was changed to MEM supplemented with 2% FBS, 1% L-glutamine, 1% NEAA 
and 20 mM ammonium chloride. The infected cells were then grown for 72 to 96 hours at 
30 ºC before harvesting the cell medium. 
The collected cell medium was centrifuged for 10 min at 6000 rpm in a Beckman 
Coulter centrifuge (rotor ID: JA-10). PEG precipitation was carried out by the addition of 
PEG-8000 to a final concentration of 8% and stirring overnight at 4 °C. The precipitates 
from this step were collected by centrifuging for 50 minutes at 9,500 rpm (rotor ID: JA-
10). The pellets were re-suspended in 10 ml of NTE buffer (20mM Tris (pH 8.0), 120 mM 
NaCl and 1 mM EDTA). The mixture was centrifuged at 3000 rpm for 5 mintues. It was 
then layered on top of a 10-35% potassium tartarate step gradient. 2 ml of a 22% sucrose 
solution in NTE buffer was added to the bottom of the gradient tubes using a Pasteur pipette. 
The tubes were then centrifuged at 32000 rpm for 2 hours in an ultracentrifuge (rotor ID: 
SW-41). Illumination of the gradient centrifuge tubes after this step showed the presence 
of purified virus as a single white band. The band region was collected and buffer 
exchanged into NTE buffer using a 100 kDa cut-off centrifugal filter (Amicon). 
 
2.8 Cryo-electron microscopy studies with NITD-249 
 The immature virus was incubated with NITD-249 at room temperature for about 
1 hour. The incubation conditions were based on information given by the Novartis Co. 
team. The pH of the virus-compound mixture was then lowered to pH 6.0 using citrate-
phosphate buffer. This mixture was applied to C-flat (1.2/1.3-4C-50) grids (EMS) and 
frozen as vitrified ice samples in liquid ethane. The grids were then analyzed at 200 kV in 
the Phillips CM200 microscope. CCD images were collected at a magnification of 11000X 
and defocus of about 3-5 µm. 
 
2.9 Plaque assay studies with NITD-029 and NITD-249 
 Plaque assays were set up using BHK-15 cells. The BHK-15 cells were grown till 
confluence on 6-well titre plates to form a single continuous layer of cells. These wells 
were then infected with 10-fold serial dilutions of mature dengue virus (DENV-2, strain 







plates were infected with virus pre-incubated for 1 hour with 50 μM (final concentration) 
of either NITD-029 or NITD-249. The final DMSO concentration in the wells was 5%. 
The wells were then overlaid with 2-3 ml of MEM plus 5% FBS and 0.8% agar. After the 
agar solidified, the wells were overlaid with 1 ml of MEM plus 5% FBS. The well-plates 
were incubated at 37 ºC in a 5% CO2 incubator for 6 days. After 6 days, the agar was 
removed gently from the well-plates. 0.1% crystal violet dye was used to stain the wells. 








3. Results and Discussion: 
 The results obtained from the individual drug candidates have been discussed 
separately in the following sections.  
 
3.1 Drug candidate: NITD-276 
3.1.1 Co-crystallization studies with dengue-E protein 
  Co-crystallization of the soluble ectodomain of the dengue-E protein with 1 mM 
of the NITD-276 compound gave regular shaped crystals (Figure A 3). The molar ratio of 




Figure A 3 Crystals of dengue E protein co-crystallized with NITD-276. 
 
 
X-ray datasets with resolution of about 3.4 Å were collected from these crystals. 
The space group was P43212 (a = 105.680 Å, b = 105.680 Å, c = 167.717 Å) with 2 
molecules in the asymmetric unit. The structure was determined using the molecular 
replacement (MR) technique with the known dengue E protein structure as a search model. 
However, the electron density map produced after structure determination did not show 
any extra density which might correspond to the density of the drug compound. Thus, it 
was concluded that the drug does not bind to the dengue E protein in solution. The 









Table A 1 X-ray data and refinement statistics for the dengue E crystals with NITD-276 
Data collection 
X-ray wavelength (Å) 0.98 
Space group P43212 
Cell dimensions  
a,b,c (in Å ) 105.724, 105.724, 169.208 
α,β,γ (in degrees) 90, 90, 90 
Resolution (Å)2 3.40 (3.46-3.40) 
Rmerge2 0.169 (0.73) 
I/ΔI2 26.4 (6.04) 
Completeness (%)2 96.98 (93.93) 
Overall Redundancy 14.3 
Refinement 
No. of reflections 13633 
Rwork/Rfree 0.34/0.42 
R.m.s deviations 
Bond length (Å) 0.0053 
Bond angles (deg.)  1.598 





3.1.2 Cryo-electron microscopy studies 
Simultaneous experiments using cryo-electron microscopy were carried out with 
NITD-276 in order to locate the binding position of the drug on the mature dengue virus. 
However, the quality of the micrographs was not very good. The final reconstruction 
obtained had a resolution worse than 25 Å and lacked detail. This could have been due to 
the low number of particles, ice contamination that was seen on the micrographs or also 







 On obtaining the results from the co-crystallization studies, followed by the 
discovery of solubility issues with NITD-276 in aqueous solutions with less than 10% 
DMSO concentration, further experiments were not carried out with this compound.  
 
3.2 Drug candidate: NITD-029 
The NITD-029 compound was soluble in 5% DMSO solution. Plaque assay studies 
were conducted using BHK-15 cells infected with dengue-2 virus that had been treated 
with NITD-029. The results from these assays are shown in Section 3.33. 
 
3.3 Drug candidate: NITD-249 
3.3.1 Iso-thermal calorimetry studies 
 The NITD-249 compound was also soluble in water in the presence of 5% DMSO. 
In order to ascertain binding of the compound to dengue E before conducting structural 
studies, Isothermal Titration Calorimetry (ITC) was carried out with NITD-249 in 10% 
DMSO solution. The results from the ITC experiments are given in Figure A 4.  
From the ITC experiments it was concluded that NITD-249 did not bind to E 



















Figure A 4 ITC binding experiments. A. Control experiment with 1mM NITD-249 
injected into sample cell containing 10% DMSO solution. B. Test experiment with 1mM 
NITD-249 injected into sample cell containing 100µM dengue-E protein. Both ligand and 
protein solution contained 10% DMSO. C. An example of an ideal ITC curve for 1:1 ligand 
































3.3.2 Cryo-electron microscopy studies with NITD-249 
 From the results of the ITC experiments, it was hypothesized that the NITD-249 
compound could bind to epitopes on the E protein that may be present only on the dengue 
virion and not on the recombinant soluble ectodomain of E protein. As the compound was 
designed to bind the hinge region between domain I and II in the E protein, it would be 
expected to block conformational changes in the E protein. Major conformational changes 
occur in the E protein on the fusion of the virus with the host cell endosomal membrane. 
In this step, the homodimeric E protein rearranges to form trimeric spike structures that 
resemble the glycoprotein spike structures of the immature virus. Low pH induces the 
above mentioned conformational changes. Low pH conformational changes can also be 
induced with immature virus particles, in which case, the spikes on the immature virus 
adopt a more flattened conformation as in the mature virus. It was thus hypothesized, that 
the drug should also be able to bind to immature dengue virus particles. Lowering of pH 
would then negatively affect the motions of the E protein and inhibit it from forming the 
smooth, mature-particle like conformation. Immature dengue was chosen as a starting point 
because it was easier to produce and more stable. Lowering of pH induces aggregation in 
case of mature virus as this exposes the fusion loop on the E protein. Aggregation at low 
pH can be avoided with immature virus particles as the pr peptide is present to mask the 
fusion loop. 
 Analysis of the grids showed that on lowering pH, the immature virus-drug mixture 
showed conformational changes of the E glycoprotein spikes towards the flattened 
conformation of mature virus in about 35% of the virus particles (Figure A 5). This was 
similar to the percentage seen on lowering pH with immature virus alone. Thus, it was 
concluded that either the drug compound did not block the expected conformational change 










Figure A 5 Dengue-2 treated with NITD-249. A and B. Dengue virus plus NITD-249 at 
neutral pH. C and D. Dengue virus plus NITD-249 at pH 6.0. The green boxes indicate 
immature particles, red boxes indicate the mature particles and the blue boxes indicate 











3.3.3 Plaque Assay studies with NITD-029 and NITD-249 
 The NITD-029 and NITD-249 compounds were incubated with dengue virus 
separately and then used to infect BHK-15 cells. In the plaque assay results shown below 
(Figure A 6), the greater the amount of darker color corresponds to higher amount of living 
cells, which in turn means lower virulence of the virus particle. Thus, if the compound 
inhibited dengue virus infection, there would be lower amount of plaques or higher amount 
of living cells when compared to the control experiments. 
The plaque assay results clearly showed that the compounds NITD-029 and NITD-
249 promoted better cell growth (or inhibit virus) only at very low virus concentrations. 
Hence, the inhibition effects of the compounds were not very good. At this point, 
information was also received from Novartis Co. (NITD) that they had stopped working 
on these drug candidates, and further work on this project was halted both at the Rossmann 






















Figure A 6 Plaque assays using BHK-15 cells infected with Dengue virus type-2 
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